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ABSTRACT 
In periods of prolonged stress and pain from strenuous exercise, the body produces chemicals 
called endorphins that help it endure pain. These natural analgesics are presumably only 
released when the level of pain intensity is at least moderately high. The PANIC/separation 
distress system is built on the same pathways as the physical pain system, and is responsible 
for the ‘mental pain’ (feelings of panic anxiety, loss and sorrow) that is associated with the 
loss of an attachment object, or separation from it. Given this overlap, it is reasonable to 
expect that endorphin release can affect depressive symptoms in a positive way. There is 
existing evidence that exercise has a beneficial effect on depressive symptoms, yet the 
underlying physiological mechanism has yet to be properly determined. The purpose of this 
three-armed prospective randomized control pilot study was therefore to try to establish this 
mechanism by investigating whether intensive exercise can improve the symptoms of 
moderate depression as a result of demonstrable increases in plasma β-endorphins. It has 
previously been established that exercise-induced β-endorphin release correlates positively 
with the intensity of the exercise.  
 
There were two central hypotheses for this study. The first was that the mechanism behind 
the improvements seen in depressive symptoms due to exercise is the same mechanism that is 
responsible for the established analgesic effect of exercise, namely endorphin release. The 
second hypothesis was that only high-intensity exercise (i.e. great that 70 of  heart rate 
reserve) will be sufficient to produce a guaranteed endorphin release, whereas moderate-
intensity exercise (just under 50% of the heart rate reserve) and very low intensive exercise 
would not be sufficient to release endorphins, and would therefore not result in an 
improvement in depressive symptoms. The main aim was therefore to investigate whether 
intensive exercise (greater than 70% of heart rate reserve) improves moderate depression, and 
if so, whether this correlates with a demonstrable increase in β-endorphins. This study 
therefore wished to determine which of low, moderate or high intensity exercise alleviates the 
symptoms of depression. It also intended to determine whether an increase in β-endorphins 
correlates to an improvement in the participants’ depression levels, and whether greater β-
endorphin release occurs during high-intensity exercise compared to low- and moderate 
intensity exercise. 
 
Male participants (n = 33) with moderate levels of depression were randomly assigned to one 
of three experimental groups of varying exercise intensities: High-intensity (       160 beats 
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per min (bpm)), Moderate intensity (       140bpm), and a low-intensity control group (under 
120bpm). All participants underwent a six-week exercise program that involved participation 
for three days per week, for one hour per day (i.e.18 sessions in total). Once weekly, the 
Hamilton Rating Scale for Depression (HAM-D) and the Montgomery Åsberg Depression 
Rating Scale (MADRS) were administered to each participant. The participants in the High- 
and Moderate-intensity exercise groups each had 5ml of blood drawn, once per week, before 
and after exercise, in order to measure their β-endorphin levels, and to track any changes in 
these levels over time. The participants in the Control group had blood samples taken twice – 
once at the start of the study (a baseline measure), before and after exercise, and once on 
completion of the study, before and after exercise. 
 
The results indicate that both Moderate- and High-intensity exercise improved the 
participants’ depression levels, while the Control group also showed some improvement, but 
not to the same extent as the other two groups. A significant difference (p = < 0.0001) was 
found when comparing the initial and final HAM-D scores between all three groups. The 
participants’ MADRS scores also improved between all three exercising groups. A significant 
difference (p = 0.0182) was found when comparing the initial scores within each of the three 
groups to their final MADRS scores. No significant difference was found in the serum β-
endorphin levels when comparing the Moderate- with the High-intensity group. The 
differences between the baseline and post-exercise serum β-endorphin measurements were 
also not significantly different for both the Moderate- and High-intensity groups (p= 0.953 
and p= 0.992 respectively), while the Control’s pre- to post levels decreased significantly (p 
< 0.017). A significant difference between the Control-, Moderate-, and High-intensity 
groups (p = <0.022) was found when comparing the three groups’ serum β-endorphin 
concentrations after they engaged in exercise.  
 
Overall, the results of this pilot study go against the hypothesis that only High-intensity 
exercise would improve symptoms of moderate depression, as both high- and moderate-
intensity exercise had a clear positive impact on depression scores. However, consistent with 
this hypothesis, very-low intensity exercise did not seem to have as beneficial an effect. The 
mechanism underlying the benefit of exercise on the symptoms of depression cannot be 
conclusively confirmed given the overall β-endorphin results. A larger sample size and more 
accurate analysis methods of β-endorphin levels are required in order to test these tentative 
findings more rigorously. 
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1. LITERATURE REVIEW 
 
Depression is a very prevalent mental disorder that affects 340 million people globally and is 
projected to become the leading cause of disability, and the second leading contributor to the 
global burden of disease (GBD) by the year 2020 (Dinas et al., 2011). Depression can have a 
detrimental effect on a sufferer’s health, mental well-being, activities of daily living, and self-
worth. Depression can affect each person at least once in their lives, and it is a mental 
disorder that most do not want to confess to having. A combination of environmental, 
genetic, biological and psychological factors can give rise to depression; for example, the loss 
of a loved one, stress from work or losing a job, trauma, a difficult relationship, or moving to 
a new location, can all trigger a depressive episode.  
 
Most doctors or psychiatrists will look to anti-depressive therapy in the form of drugs, 
psychotherapy, support groups, or lifestyle/behavioural modification in order to help patients 
diagnosed with depression symptoms. Admitting to suffering from depression can be difficult 
and embarrassing. Most people do not seek help, or receive inadequate treatment; Stein 
(2005) estimates that a mere quarter to one half of patients with depression in the United 
States receive adequate care. Moreover, many people with depression avail themselves of 
complementary and alternative therapies, which perhaps speaks to their dissatisfaction with, 
or inadequate access to, conventional treatments (Stein, 2005). Not all treatments work for 
everyone, and it might take a depression sufferer numerous attempts at trying different 
treatments in order to help alleviate his/her symptoms. This may cause anguish, and can 
potentially lead to doubt over the treatments, thereby resulting in discontinuation and 
remission.  
 
There is existing evidence that exercise has a beneficial effect on depressive symptoms. 
However, the physiological basis of the antidepressant effect of exercise has not been fully 
investigated. Whilst key research needs to be undertaken in order to investigate the 
mechanisms responsible for this relationship, the fact remains that physical activity is good 
for physical and mental health, and therefore beneficial for overall well-being (Blake, 2012). 
There are a lot of factors to consider. Everyone responds differently to exercise: some love it 
and some hate it. Motivation is key to living an active lifestyle and for some finding the time 
or motivation to exercise is difficult. Furthermore, is 30 minutes of physical activity per day, 
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five times per week enough to make an impact? Even though numerous studies suggest that 
exercise is beneficial in alleviating the symptoms of depression, it is still unclear how much, 
how frequent, how intense this exercise should be, and what kind of exercise is best. In 
periods of prolonged stress and pain from strenuous exercise, the body produces chemicals 
called endorphins that help the individual endure pain. However, it is understood that these 
natural ‘painkillers’ are only released once exercise intensity has reached moderate to high 
levels.   
 
To date, there have been few clinical-control trials looking at exercise and its effects on 
depression. Most, if not all, studies find that exercise is an effective treatment and is 
comparable to antidepressant therapy. However, it is still unclear which mode, frequency or 
intensity of exercise is most effective, and the physiological mechanism underlying exercise’s 
antidepressant effect has yet to be established. There are very few studies that have looked at 
different intensities of exercise to alleviate depression. The relationship between exercise and 
endorphins is another area that has been inadequately studied. 
 
What is depression? 
Depression refers to a wide range of mental health problems characterized by the absence of 
a positive affect (a loss of interest and enjoyment in ordinary things and experiences), low 
mood, and a range of associated emotional, cognitive, physical and behavioural symptoms 
(NICE, 2007). Individuals suffering from depression show signs of decreased energy and low 
levels of physical activity, and a lack of motivation and interest towards hobbies or tasks that 
they once enjoyed  which may lead to feelings of guilt, decreased appetite or sleep, low 
self-worth, and low levels of mood. These symptoms may become chronic when they carry 
on for months, which can even lead to disability or suicide in extreme cases.  
 
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) 
categorizes major depressive disorder (MDD) as a clinical syndrome characterized by 
depressive mood or loss of interest in activities, which last for two weeks or more, and which 
are accompanied by at least four additional features involving emotional, physiological, or 
cognitive symptoms; for example, sleep disturbances, changes in eating habits, fatigue, 
suicidal thoughts, reduced ability to concentrate (DSM-V, American Psychiatric Association,  
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2013) (Josefsson, Lindwall, & Archer, 2013). Depression is a common and important cause 
of morbidity and mortality worldwide.   
 
Treating depression 
There are many forms of treatment for depression, the most popular being antidepressants 
and psychotherapy. Even though numerous treatment options are available, not all therapies 
work for everyone. Most depression suffers will try one form of treatment and, if it is not 
successful, will then be reluctant to try another. Antidepressant therapy in the form of drugs 
such as paroxetine (Paxil), fluoxetine (Prozac), sertraline (Zoloft), fluvoxamine (Luvox), and 
citalopram (Celexa) may have many side effects. Acute side effects include: upset stomach, 
nausea, headache, fatigue, dry mouth, and nervousness. Some of the more chronic side effects 
include: sleep disturbances, increased risk of cardiovascular disease, sexual dysfunction, 
weight gain, and insomnia. Furthermore, adherence to antidepressant medications is often 
poor, and patients frequently discontinue their antidepressant therapy prematurely. It has been 
suggested that approximately 50% of psychiatric patients and 50% of primary care patients, 
are non-adherent when assessed 6-months after the initiation of treatment (Blake, 2012).   
 
There are many different forms of psychological treatment, including cognitive behavioural 
therapy (CBT); behaviour therapy (BT); interpersonal psychotherapy (IPT); problem-solving 
therapy (PST); counselling, short-term psychodynamic psychotherapy; and couple-focused 
therapies (NICE, 2007). There has been increasing interest in the potential role of alternative 
therapies for the management of depression, such as music therapy, light therapy, 
acupuncture, family therapy, marital therapy, relaxation, and exercise (Mead et al., 2009). 
However, with all of these treatment options available, why is the burden of depression 
increasing each year? Of the 130 cases of depression (including mild cases) per 1000 
population (Great Britain), only 80 will consult their GP. The most common reasons given 
for reluctance to contact the family doctor were: did not think anyone could help (28%); a 
problem one should be able to cope with (28%); did not think it was necessary to contact a 
doctor (17%); thought the problem would get better by itself (15%); too embarrassed to 
discuss it with anyone (13%); afraid of the consequences (e.g. treatment, tests, 
hospitalisation, being sectioned - 10%) (Meltzer et al., 2003). 
 
Evidence shows that pharmacotherapy is only effective in about one third of depressed 
patients, and some only have a partial response to treatment, thereby prompting the need to 
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identify other forms of treatment. Exercise is becoming more popular for treating depression, 
and can be used in conjunction with other treatments. There are a number of possible 
theoretical reasons as to why exercise may improve depression (Mead et al., 2009). Physical 
exercise has also received a significant amount of attention with regard to stress reduction 
and improving mood (Hamer et al., 2012). Physical activity, including exercise, is a relatively 
inexpensive and non-harmful lifestyle intervention, which lacks the side-effects of 
medication and does not require the introspective ability required for most psychotherapies 
(Kruisdijk et al, 2012).   
 
Benefits of exercise and physical activity 
Regular physical activity is associated with better mental health and wellbeing (Hammer et 
al., 2012). The benefits of engaging in regular physical activity include an increased work 
capacity (U.S Department of Health and Human Services, 1996); decreased body fat and 
increased lean body tissue (Sidney et al., 1977); increased bone density (Smith et al., 1976); 
and lower ratings of coronary heart disease (CHD) (Paffenbarger et al., 1978), diabetes 
mellitus, hypertension (Tipon et al., 1991) and cancer (Lee et al., 1991). Regular physical 
activity and exercise can also assist in improving one’s mood and motivation (Ntoumanis et 
al.,  999), a s well as enhance their quality of life, improve one’s capacity for work and 
recreation, and altering one’s rate of decline in functional status (Shephard et al.,  99 ) . 
 
The Healthy People 2020 Physical Activity Objective PA-2.1 (U.S Department of Health and 
Human Services, 2011) highlights the need for every adult to engage in moderate aerobic 
physical activity for at least 150 min per week or 75 min of vigorous aerobic physical activity 
per week or an equivalent combination. With depression having such a high prevalence, 
affecting 340 million people globally, it is projected to become the leading cause of 
disability, and the second leading contributor to the global burden of disease by the year 2020 
(Dinas et al., 2011). In looking at exercise as a means to cure or lessen the symptoms of 
depression, there is sufficient evidence showing that exercise is an effective mechanism. 
Goodwin et al. (2003) examined 5877 individuals aged 15-54 years and showed that those 
who were more physically active reported lower levels of depression than non-active 
individuals. Paffenbarger and colleagues conducted a classic study in 1994. They examined 
the questionnaires of 31 000 Harvard College graduates in 1962, 1966, 1977 and 1988 and 
found that physically active individuals reports lower depression levels than their physically 
inactive peers.  
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Dinas et al. (2011) found that exercise and being physically active have beneficial results on 
depressive symptoms and are comparable to those of anti-depressive therapy. Blumenthal et 
al. (2012) looked at a combination of the medication sertraline and exercise and how 
effective this was in alleviating depressive symptoms. These authors found that a 
combination of both was more effective in reducing depressive symptoms compared to 
placebo in patients with coronary heart disease. Rimer et al. (1996) and Jodefsson et al. 
(2013) found that exercise seemed to improve depressive symptoms when compared to a 
control and no treatment condition in people diagnosed with depression. Dunn et al. (2005) 
looked at different doses of exercise and found that a dose consistent with ACSM’s daily-
recommended amount of physical activity per week (i.e. 30 minutes of an aerobic activity 
five days per week, or vigorous activity for a minimum of 20 minutes, three days per week) 
was sufficient in reducing depressive symptoms. Mead et al (2009) found that the effect of 
exercise was not significantly different to that of cognitive therapy, which means that 
individuals suffering from depression might be able to either partake in exercise to alleviate 
depression, or do cognitive therapy, given that they seem to yield similar results. Kruisdijk et 
al. (2012) also found that exercise as a remedy for depression can be used as a standalone 
intervention or as an add-on intervention. Moses et al. (1989) took sedentary individuals and 
assigned them to four exercise conditions, with their findings being that psychological 
benefits were seen with the moderate exercise condition, but not with the high exercise or 
attention-placebo conditions. Krogh et al. (2011) found a short-term benefit for exercise as a 
remedy for depression in clinically depressed patients. 
 
Exercise as a means to alleviate depression 
Encouraging evidence has shown that exercise and physical activity have beneficial effects 
on symptoms of depression that are often comparable to those of antidepressant treatments 
(Dinas et al., 2011). Engaging in regular exercise does not carry a stigma, is relatively low in 
cost, and can be done outside standard medical settings. In addition, exercise may be a more 
acceptable treatment for some (e.g. pregnant women and adolescents) because of its relative 
safety and lack of side effects compared to antidepressant drug treatments (Dunn et al., 
2002). Prescribing exercise to treat depression is still a fairly new concept, and knowing how 
much exercise is required, and what duration is necessary, are issues that still require further 
investigation. In general, exercise is good for overall well-being and fitness, as prescribed by 
the American College of Sports Science (ACSM)  i.e. 30 minutes of an aerobic activity 
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five days per week, or vigorous activity for a minimum of 20 minutes three days per week 
(ACSM’s guide for Exercise Testing and Prescription, 8th edition, p.8). To date, research is 
showing that exercise and physical activity can be used as therapeutic means for acute and 
chronic depression in the general population, as well as in hypertensive and cardiovascular 
disease patients (Dinas et al., 2011). Exercise also increases a person’s feeling of well-being 
and is an effective therapy for many chronic diseases in older adults. If one searches for 
studies using the key words depression, exercise, and physical activity, one will find 
hundreds of articles that support exercise as a means to cure depression, or to minimize its 
symptoms.     
 
The burden of depression 
The GBD study highlights how mild to moderate MDD ranks second behind ischemic heart 
disease for years of life lost due to premature death or disability (Dunn et al., 2005). 
Depression has serious effects on a person’s health and can lead to heart disease and even 
death if left untreated. Ferrari et al. (2013) looked at the burden that depression has on health 
and they found depressive disorders were a leading cause of disease burden in the 1990 and 
2000 GBD studies. The GBD initiative, which aims to provide data that can be used to 
improve public-health policy and the knowledge that depressive disorders are a leading cause 
of disease burden worldwide, has helped to prioritize depressive disorders in global public-
health agendas. Researchers collected data from published articles on the prevalence, 
incidence, remission rates, and burden of MDD and dysthymia (sub-clinical depression) and 
on the excess deaths caused by these disorders. Major depressive disorder was also a 
contributor of burden and added to the prevalence of suicide and ischemic heart disease. 
These findings emphasize the importance of making depressive disorders a public-health 
priority and implementing cost-effective interventions to reduce its burden (Ferrari et al., 
2013).   
 
Depression often co-occurs with other chronic diseases and can worsen their associated 
health outcome. Prevalence values for four chronic physical diseases — angina, arthritis, 
asthma, and diabetes — were also estimated using algorithms derived via a Diagnostic Item 
Probability Study (Moussavi et al., 2007). These data came from 245 404 participants from 
60 countries, and from all regions of the world. The authors found that a significant 
percentage of respondents with any one of the chronic physical conditions also had 
depression. For respondents with diabetes, at the worldwide level, 9.3% (7.3–11.3) also had 
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depression; 10.7% (9.1–12.3) with arthritis also had depression; 15.0% (12.9–17.2) with 
angina; and the respondents with asthma had the highest prevalence of depression at 18.1% 
(15.9–20.3). For the 7.1% (6.6–7.6) of respondents who had comorbidity of two or more 
chronic physical conditions, nearly a quarter (23%) also had depression in addition to their 
existing comorbid conditions. Thus, the prevalence of depression in individuals with chronic 
diseases is significantly higher (3.2%, p<0.0001) than in individuals without such conditions 
(Moussavi et al., 2007). By examining these results, it is clear that depression had the largest 
effect on worsening mean health scores when compared to other chronic conditions. If a 
participant had one or more chronic diseases coupled with depression, then s/he had the worst 
health scores overall. These results indicate the urgency needed in addressing depression as a 
public-health priority in order to reduce disease burden and disability, and to improve the 
overall health of populations (Moussavi et al., 2007).  
 
Depression also plays a detrimental role in cardiovascular disease (CVD). The relationship 
between depression and CVD is bidirectional: just as depression increases the risk for CVD, 
so too the development of CVD increases the risk for depression (Rozanski, 2012). To the 
knowledge of Blumenthal and co-workers, no randomized clinical trial has examined the 
effects of exercise on depression in patients with CVD. Therefore, these authors assessed the 
efficacy of exercise and antidepressant medication in reducing depressive symptoms and 
improving cardiovascular biomarkers in depressed patients with coronary heart disease 
(Blumenthal et al., 2012). In their UPBEAT (Understanding the Prognostic Benefits of 
Exercise and Antidepressant Therapy) study, 100 outpatients with coronary heart disease and 
elevated depressive symptoms were randomized to either 4 months of aerobic exercise (3 
times/week), the drug sertraline (50-200 mg/day), or a placebo. Other assessments of 
cardiovascular biomarkers were made, including heart rate variability, endothelial function, 
baroreflex sensitivity, inflammation, and platelet function. This study found that after 16 
weeks, all groups showed improvement based on Hamilton Rating Scale for Depression 
scores. Their participants in both the aerobic exercise (mean -7.5; 95% confidence interval: -
9.8 to -5.0) and the sertraline (mean -6.1; 95% confidence interval: -8.4 to -3.9) groups 
achieved larger reductions in depressive symptoms compared with those receiving the 
placebo (mean -4.5; 95% confidence interval: -7.6 to -1.5; p = 0.034). Exercise and sertraline 
were equally effective at reducing depressive symptoms (p = 0.607). Exercise and medication 
tended to result in greater improvements in heart rate variability compared with placebo (p = 
0.052); and exercise tended to result in greater improvements in heart rate variability 
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compared with sertraline (p = 0.093) (Blumenthal et al., 2012). In conclusion, this study 
found that both the exercise and sertraline groups had greater reductions in depressive 
symptoms compared to the placebo group. Exercise is seen to have cardiopulmonary benefits 
and was effective in lowering depressive symptoms. These findings add to the growing body 
of research suggesting that exercise may be a viable alternative to traditional 
psychopharmacological treatments of depression. 
 
The effect of exercise and physical activity on depression 
Based on the currently available evidence, it is clear that exercise and physical activity have 
beneficial effects on depression symptoms that are comparable to those of antidepressant 
treatments. Dinas et al. (2011) reviewed the published evidence covering topics such as the 
link between β-endorphins and exercise; exercise, physical activity and depression; exercise 
and physical activity as treatments for depression; the properties of exercise stimuli; 
intervention programs; and the efficacy of exercise and physical activity for treating 
depression in diseased individuals. These authors found that exercise of sufficient intensity 
and duration increased circulating β-endorphin levels, which positively affected mood. 
However, they concluded that the mechanism by which β-endorphins decrease depressive 
symptoms is incomplete. With regard to exercise and physical activity, Dinas et al. found an 
inverse linear relationship: an increase in exercise frequency reveals lower reported levels of 
depression and similarly, decreased activity shows higher levels of depression. Looking at 
exercise and physical activity as treatment for depression, the authors found that aerobic 
exercise programs were more successful than placebo and pharmacological treatments in 
reducing the symptoms of depression. For the properties of exercise stimulus, they found that 
the duration of exercise interventions is not clearly related to outcome, but the more intense 
the exercise regime, the larger the improvements in mood seem to be. If aerobic and 
resistance training is combined, then they have a stronger effect than aerobic and flexibility 
training.   
 
Supervised programs also show promising effects, whereas participants in unsupervised 
programs do not have the encouragement to continue, and consequently lose the interest to 
complete the program. On the topic of exercise and physical activity for treating depression 
in diseased individuals, Dinas et al. (2011) found exercise to be beneficial for patients who 
were recovering from heart attacks in improving their depressive symptoms, but these 
benefits for cardiovascular mortality/morbidity may be independent of their effects on 
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depression. The authors highlight that more research needs to be done given the 
methodological limitations of the existing research, which preclude a clear identification of 
the optimum exercise properties for treating depression, while the risk and cost effectiveness 
associated with relevant interventions remain unknown (Dinas et al., 2011). Overall, these 
authors found that the evidence presented suggested that exercise and physical activity have 
beneficial effects on depression symptoms that are comparable to those of antidepressant 
treatments. 
 
Mead and co-workers (2009) did a review on exercise in relation to depression in order to 
examine its effectiveness in the treatment of depression. For this review, twenty-eight trials 
fulfilled their inclusion criteria, of which 25 provided data for meta-analyses. These authors 
state that depression is commonly treated with antidepressants or psychological therapies, or 
a combination of both. However, a Cochrane review (Moncrieff, 2003) found only small 
differences between antidepressant medications and active placebos. Furthermore, 
antidepressants may have adverse side effects, adherence can be poor, and there is a lag time 
between one starting antidepressants and improvements in mood. Psychological treatments 
are generally free from side effects, but some people may not wish to attend psychotherapy 
because of perceived stigma (Mead et al., 2009). Overall, this review revealed that 
methodological factors, in particular intention-to-treat analyses and blinding of outcome 
assessors, influenced the effect size and the significance of these effects. Hence, further trials 
that are methodologically robust are required in order to determine more accurately, the effect 
of exercise on depression. The authors also found that the effect of exercise was not 
significantly different from that of cognitive therapy.  
 
One paragraph in the above-mentioned review that is interesting and relevant to the present 
study is where the authors looked at data regarding the intensity of exercise. Here, they found 
that high-intensity exercise was more effective than low-intensity exercise, and the same 
applied for resistance training (Singh, 2005). The authors also found that mood correlated 
with fitness (Blumenthal, 1999; Pinchasov, 2000; Martinsen, 1985; Singh, 2005). They 
suggest additional subgroup analyses that look at supervised verses unsupervised training, 
indoor verses outdoor training, and individual verses group training. There is also a need for 
studies that are larger in terms of sample size in order for the effect size to have statistical 
significance.  
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A less recent review by Rimer and co-workers (1996) sought to determine the effectiveness 
of exercise in the treatment of depression by looking at thirty-two trials (1858 participants) 
that fulfilled their inclusion criteria, of which 30 provided data for meta-analyses. In six trials 
that compared exercise with cognitive behavioural therapy (152 participants), the effect of 
exercise was not significantly different from that of cognitive therapy. The authors concluded 
that exercise seemed to improve depressive symptoms in people with a diagnosis of 
depression when compared with no treatment or control intervention; however, since analyses 
of methodologically robust trials show a much smaller effect in favour of exercise, some 
caution is required when interpreting these results (Rimer et al., 1996). 
 
Another meta-analysis and systematic review by Josefsson et al. (2013) looked at physical 
exercise interventions in depressive disorders in order to determine the efficacy of: (i) 
exercise in reducing symptoms of depression compared with no treatment; (ii) placebo 
conditions; and (iii) usual care among clinically defined depressed adults (Josefsson et al., 
2013). Here, the authors looked at 89 studies, of which 15 passed the inclusion criteria and 13 
presented adequate information for calculating effect size. The results of the meta-analysis 
showed adequate evidence that physical exercise reduces depression, and showed a 
significantly large overall effect favouring exercise intervention. However, the authors also 
state that it is not possible to determine exactly how effective exercise is in reducing 
depression symptoms in clinical and nonclinical depressed populations respectively.  
 
Krogh et al. (2011) have also conducted a systemic review and meta-analysis that examined 
the effect of exercise in clinically depressed adults. These authors identified thirteen trials 
that fulfilled their inclusion criteria, of which eight had adequate allocation concealment, six 
with blinded outcome, and five used intention-to-treat analyses. Findings indicated that there 
was an inverse association between duration of intervention and the magnitude of the 
association of exercise with depression (P=.002). Pooled analysis of five trials with long-term 
follow-up (i.e. that examined outcomes beyond the end of the intervention) suggested no 
long-term benefit (SMD, – .  ; 9 % CI, − .28 to  .26) . Only three studies were assessed as 
high quality (adequately concealed random allocation, blinded outcome assessment, and 
intention-to-treat analysis). When the results from these studies were pooled, the estimated 
beneficial effect of exercise was more modest (SMD, − . 9; 9 % CI, − . 7  to  .  )  than the 
pooled result for all 13 studies, with no strong evidence of benefit (Krogh et al., 2011). From 
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their results, these authors concluded that exercise may have a small short-term effect on 
depression, but it cannot yet be recommended as a treatment for clinical depression. 
 
Exercise is, of course, not the only solution to the growing problem of depression worldwide, 
and it will not be appropriate for all depressed people. On the other hand, this limitation 
applies to all traditional treatments; that is to say, medication and psychotherapy are also not 
suitable for everyone (Josefsson et al., 2013).   
 
The overall conclusion that is reached by most authors is that good quality research needs to 
be conducted on clinical populations, with allowance for adequate follow up. According to 
Mead and Rimer, there is also a need for studies that are higher in methodological quality; 
that is, studies involving adequate allocation concealment, blinding, and intention-to-treat 
analyses. Research that is of poor methodological quality can lead to inaccurate or skewed 
effect sizes. 
 
Dose response of exercise as treatment for depression 
Based on the knowledge that exercise is an effective antidepressant treatment, the question is: 
what ‘dosage’ is required to be most beneficial? There are various dose-response questions 
that persist with respect to depression and exercise, which include: 'Is there a minimal dose 
that is required to produce benefits?’ and ‘Is there a maximal threshold?’. The present study 
will offer substantial evidence towards addressing these questions, but further research is still 
required in order to enable public-health guidelines for the mental health benefits of exercise 
to be established (Dunn et al., 2002). 
 
The Depression Outcomes Study of Exercise (DOSE) by Dunn et al. (2002) involved a 
randomized clinical trial to determine whether exercise is an efficacious treatment for mild to 
moderate MDD in adults aged between 20 and 45 years. This study was conducted between 
1998 and 2001, analyzed in 2002 and 2003, and published in 2005. It had two major 
objectives: (i) “to determine the efficacy of aerobic exercise as a sole treatment of mild to 
moderate depression, and (ii) to determine the dose-relationship between different amounts 
and frequencies of aerobic exercise with the reduction of depressive symptoms.” This study 
involved a 2x2 factorial design, with an exercise placebo as the control group. The two 
exercise factors manipulated were total weekly energy expenditure per kilogram of body 
weight (7 kcal/kg/week and 17.5 kcal/kg/week), and frequency of exercise (3 days/week or 5 
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days/week). Therefore, for a 70-kg person, the total weekly energy expenditure would be 490 
kcal/week if s/he received the 7 kcal/kg/week dose, or 1225 kcal if s/he received the 17.5 
kcal/kg/week dose. The total energy expenditure was then divided among the three days or 
the five days for the dose of exercise per session. Eighty men and women who were 
diagnosed with a Structured Clinical Interview for Depression, and who had mild (HRSD 12-
16) to moderate (HRSD 17-25) MDD, were randomized to one of five of the groups above as 
follows: 7.0 kcal/ kg/week in 3 days/week; 7.0 kcal/kg/week in 5 days/week; 17.5 
kcal/kg/week in 3 days/week; 17.5 kcal/kg/week in 5 days/week; or 3 days/week of stretching 
and flexibility exercises for 15 to 20 minutes per session. The participants had their 
symptoms of depression measured once per week by a “blinded” clinician.  
 
The primary outcome measure for this study was the change in the HRSD17 (Hamilton Rating 
Scale of Depression 17-item) score from baseline to 12 weeks. The secondary outcomes were 
response (50% reduction in symptoms) and remission (HRSD17 score of ≤ 7).  The secondary 
outcome measures were the Inventory of Depressive Symptoms (clinician and self-report), 
the HRSD scores at 24 weeks, cardiorespiratory fitness, self-efficacy, and quality of life. The 
findings showed that the main effect of energy expenditure in reducing HRSD17 scores at 12 
weeks was significant. Adjusted mean HRSD17 scores at 12 weeks were reduced 47% from 
baseline for Public Health Dose (PHD), compared with 30% for Low Dose (LD) and 29% for 
control. There was no main effect of exercise frequency at 12 weeks. The authors concluded 
that aerobic exercise at a dose consistent with public health recommendations is an effective 
treatment for MDD of mild to moderate severity. A lower dose is comparable to placebo 
effect (Dunn et al., 2005). This study shows a specific dose of aerobic exercise that can be 
administered in the treatment for depressive symptoms, and this dose that is needed is 
equivalent to the consensus public health recommendations. The only drawback is that the 
authors did not blind their participants to their treatment assignments. Consequently, as 
participants become aware that they were in the placebo group, they were more eager to drop 
out.  
 
This study by Dunn et al. can be used as a benchmark for other studies on the topic of 
exercise as a method of alleviating depressive symptoms. It shows that exercise at different 
energy expenditures and frequencies is efficacious in the treatment of depression; however, 
further research needs to be done in order to establish proper guidelines regarding the benefits 
that exercise has on mental health.   
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Association between physical activity and mental disorders 
Goodwin (2003) examined the association between physical activity and mental disorders 
among adults in the United States. Multiple logistic regression analyses were used to compare 
the prevalence of mental disorders among those who did and did not report regular physical 
activity. This was done using data from the National Comorbidity Survey (n = 8098), a 
nationally representative sample of adults ages 15–54 in the United States. Slightly more than 
one-half of adults reported regular physical activity (60.3%). Regular physical activity was 
associated with a significantly decreased prevalence of current major depression and anxiety 
disorders, but was not significantly associated with other affective disorders, substance use, 
or psychotic disorders. The association between regular physical activity and lower 
prevalence of current major depression (OR = 0.75 (0.6, 0.94)), panic attacks (OR = 0.73 
(0.56, 0.96)), social phobia (OR = 0.65 (0.53, 0.8)), specific phobia (OR = 0.78 (0.63, 0.97)), 
and agoraphobia (OR = 0.64 (0.43, 0.94)) persisted after adjusting for differences in 
sociodemographic characteristics, self-reported physical disorders, and comorbid mental 
disorders. Self-reported frequency of physical activity also showed a dose–response relation 
with current mental disorders. In conclusion, these data document a negative association 
between regular physical activity and depression and anxiety disorders among adults in the 
U.S. population (Goodwin, 2003). This study did not have a clear definition of what they 
consider to be “regular” physical activity and this might have caused confusion with regard to 
the frequency with which the participants reported engaging in exercise. 
 
Treating depression and depression-like behaviour with physical activity  
Physical activity (PA) is increasingly investigated as a preventative, early intervention and 
treatment option for depression. Interest in investigating PA may have risen for a number of 
reasons, including that the burden of depression is increasing, so novel therapeutic and 
preventative options were required. In looking at a review of studies, Eyre et al. (2013) found 
the investigation of the neuroimmune effects of PA on depression and depression-like 
behaviour is a rapidly developing and important field. This paper summarizes the most recent 
findings in the field, and proposes a model in which PA enhances the beneficial effects of the 
neuroimmune system and reduces the detrimental effects of the neuroimmune system. 
Physical activity appears to increase the following factors: interleukin (IL)-10, IL-6 (acutely), 
macrophage migration inhibitory factor, central nervous system-specific autoreactive CD4+T 
cells, M2 microglia, quiescent astro- cytes, CX3CL1, and insulin-like growth factor-1. On the 
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other hand, PA appears to reduce detrimental neuroimmune factors such as: Th1/Th2 balance, 
pro-inflammatory cytokines, C-reactive protein, M1 microglia, and reactive astrocytes. The 
beneficial effects of PA are likely to occur centrally and peripherally (e.g. inflammatory 
markers in visceral fat reduction) (Eyre et al., 2013).  
 
Hamer and colleagues (2012) reviewed 13 prospective cohort epidemiological studies 
examining the association between physical activity and risk of future depression. The 
sample sized was 73 487 participants, with three cohorts consisting of women only, three of 
men only, and the remaining seven of mixed gender. Participants were healthy and not 
clinically depressed at the baseline assessment, and physical activity levels were assessed 
through self-reported measures. Depression was measured using a variety of methods, 
including a physician diagnosis and the administration of different validated psychometric 
tools, such as the Centre of Epidemiologic Studies of Depression Scale. The follow-up period 
ranged from two to 25 years. The study found that the pooled odds ratio (OR) of depression 
in the physically active participants compared with the sedentary participants was 0.78 (95% 
CI, 0.71-0.86, P<0.001). This finding suggests that the active participants had a 22% reduced 
risk of developing depressive symptoms. Another interesting finding was that the effects of 
physical activity appeared to be stronger in women (OR=0.81, 0.66-0.99, P=0.045), since 
women generally report more psychological distress and depression than men do. In 
conclusion, PA seems to be independently associated with the risk of becoming depressed, 
and regular exercise is associated with higher positive mood and lower negative mood 
symptoms (Hamer et al., 2012). 
 
Hamer et al. (2012) also examined the association between depressive symptoms and 
inflammatory risk markers. The link between both mood and exercise with inflammatory 
pathways led them to hypothesize that better mental wellbeing experienced by regular 
exercisers might be partly explained by an underlying neurotransmitter mechanism. If a 
person experiences alterations in neurotransmitter function that involve serotonin, 
norepinephrine, and dopamine, then this induces depression. “Exercise is thought to alter 
serotonin metabolism, release endogenous opioids, and increase central noradrenergic 
neurotransmission which may all contribute to antidepressant and anxiolytic effects” (Hamer 
et al., 2012). A third section in this paper looked at the exercise withdrawal paradigm. The 
authors hypothesized that mood disturbances caused by withdrawal from regular exercise 
might act as a mild inflammatory stimulus. In asking habitual exercisers to withdraw from 
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their regular training for two weeks, this study found significantly higher inflammatory 
responses to mental stress compared to those with low or no mood disturbance. The study 
also found that participants in the highest category of mood disturbance demonstrated the 
greatest inflammatory response to mental stress. Overall, this paper shows that exercise can 
play a big role in improving mental health and wellbeing, either due to the inflammatory 
response, the exercise paradigm, or due to being more physically active. The only negative 
aspect of this research is the fact that the participants did self-reported physical activity levels 
for the epidemiology study. This may not be as accurate as, for example, an accelerometer 
might have been given since each participant may have had a different understanding of how 
fit s/he thought s/he was. 
 
β-endorphin is 31 amino acids long that is the result of processing the precursor 
proopiomelanocortin (POMC), and is classed as an endogenous opioid peptide 
neurotransmitter. β-endorphin is contained in neurons in both the central and peripheral 
nervous system. β-endorphin is an agonist of opioid receptors, which gives it analgesic 
properties ― the body produces this peptide to numb or dull pain 
(http://www.mdbioproducts.com/products/elisas/%CE%B2-endorphin-elisa).  
 
Øktedalen et al. (2001) looked at the influence of physical and mental training on plasma β-
endorphin level and pain perception following intensive physical exercise. The study aimed 
to investigate a possible correlation between increase in circulating blood levels of β-
endorphin and decrease in pain perception after short-term intensive physical exercise. The 
authors also wanted to explore whether plasma β-endorphin levels and pain perception were 
influenced by regular physical training or mental training, and to examine whether there were 
differences in response between trained and untrained subjects. The intervention period lasted 
six months, which involved twenty physically trained males who did regular physical 
endurance training. Of the twenty participants, eleven were randomized to perform additional 
mental training (ACEM meditation) on a daily basis. Nine untrained males were in the 
control group and were investigated only at baseline. Each participant had his VO2max 
measured during treadmill exercise, and pain perception was measured using an ischemic 
pain test both before and after the VO2max test. Blood samples for β-endorphin levels were 
taken both before and after the tests. Findings showed that there was no statistically 
significant difference in VO2max among the two groups of trained subjects, either before or 
after the intervention period (before: median 56.0 (range 43.7–66.1) ml kg-1 min-1 in the 
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meditation group; 57.5 (range 43.7–75.9) ml kg-1 min-1 in the exercise control group; after: 
56.2 (range 42.8–65.5) ml kg-1 min-1 in the meditation group; 58.1 (range 46.3–73.1) ml kg-1 
min-1 in the exercise control group). The untrained control group showed a median VO2max of 
44.1 (range 39.3–53.2) ml kg-1 min-1, which was smaller than for the trained groups (p < 
0.05). 
 
For the endorphin levels, the plasma level in the above-mentioned study decreased from 
13.6nmol l-1 to the level of 7.2 nmol l-1 (p = 0.005) after an intervention period of six months 
involving regular physical training. Practicing meditation regularly for six months did not 
influence the basal plasma level of β-endorphin and there was no significant difference in 
basal endorphin level between the trained and the untrained subjects. Short-term meditation 
of 30 min duration did not alter the plasma level (before: 5.8 nmol l-1 ± 0.6; after: 5.4 nmol l-1 
±0.5). The level was no different from the basal level measured after six months of 
intervention. The VO2 max test caused a two-fold increase in plasma level (p < 0.001) that 
remained elevated for the first five minutes after the exercise. There was no significant 
difference in exercise-induced response between the trained and the untrained subjects. 
Neither six months of regular physical training, nor six months of regular mental training had 
any effect on the exercise-induced β-endorphin response.   
 
For pain perception, there was no significant change in pain assessment between the trained 
and untrained subjects. Intensive physical exercise (VO2 max test) reduced the pain perception 
significantly (p < 0.001), as well as the time course (p < 0.01), but the post-exercise analgesic 
effect was not different between the trained and the untrained subjects. The plasma level of β-
endorphins was only highly increased after short-term intensive physical exercise. Other 
exercise studies indicate that the release of β-endorphins is dependent more on the relative 
than the absolute amount of exercise, and that exercise intensities of at least 70 percent of 
VO2 max must be reached before the plasma level of β-endorphins increases (Øktedalen et al., 
2001). In conclusion, regular mental training had no impact on circulatory β-endorphin levels 
or on pain perception, and regular physical training increased pain tolerance. This study 
relates to the present study with respect to examining the basal β-endorphin concentrations. 
As Øktedalen et al. (2001) stated, for the release of β-endorphins to occur, at least 70 percent 
of VO2 max test must be reached. This is very difficult to achieve with people who do not 
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exercise regularly and their baseline will be very low, meaning that they will have to push 
themselves very hard in order to achieve an increased release of β-endorphins. 
 
The effect of running therapy on depression 
Kruisdijk et al. (2012) published a proposal to examine the effectiveness of exercise therapy 
on depression through running (RT) and Nordic walking (NW). In addition, the participants 
will also receive usual care (i.e. antidepressant medication and/or cognitive and/or 
interpersonal therapy). The authors hypothesize that in conjunction with usual care, adding 
exercise therapy will result in a larger reduction in depressive symptoms. Participants will be 
randomized into one of two groups: a control group who receive usual care and a treatment 
program consisting of pharmacotherapy and/or sociotherapy, psychotherapy, psycho-
education and indicated nonverbal therapies; and an intervention group who will be allowed 
to exercise at low intensity as part of their daily program. The intervention group will receive 
six months of supervised exercise therapy for one hour per week and were instructed to train 
unsupervised for one hour per week (a combination of about 40 exercise sessions).  
 
Those in the intervention group will be invited to take part in RT or NW for 30 minutes 
continuously (at 60% of max heart rate). If these participants are not comfortable, or are 
unable to run due to medical contra-indications or muscular-skeleto problems, then they will 
do the NW protocol. The study will use the HRSD to determine severity of depression and 
eligibility includes a score of ≥ 4.  Other health measurements, such as cardiovascular fitness 
using a sub maximal cycling test and biometric information will be gathered, and blood 
samples will be collected for metabolic parameters. Co-morbidity with pain, anxiety and 
personality traits will also be examined, as will quality of life and cost-effectiveness 
(Kruisdijk, 2012). Although testing still needs to be done, the authors inferred that exercise as 
a treatment for depression can be used as a stand-alone intervention, or as an add-on 
intervention. This protocol can be used as an example, and it will be interesting to see the 
results. Kruisdijk et al. also state that this is the first high quality large trial examining the 
effectiveness of exercise as an add-on treatment for depression in adult patients in specialized 
mental-health care. 
 
The effect of different exercise intensities on mood and mental well-being 
Moses et al. (1989) studied the effects of exercise training on mental well-being in the normal 
population. This study compared the effects of two aerobic training programmes of different 
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intensities on mood and mental well-being with those of a credible attention-placebo 
condition. The study took sedentary adult volunteers and assigned them to one of four 
conditions: high exercise, moderate exercise, attention-placebo, and a waiting list. Training 
was done over a 10-week period, and consisted of one supervised and three unsupervised 
sessions per week for each condition. The high exercise group fulfilled the recommendations 
of the American College of Sports Science (ACSM), which requires exercise on three to five 
days per week, with 15 to 60 minutes of continuous aerobic activity at 60 to 90% of HRmax. 
The participants took part in a walk-jog programme for continuous exercise of 30 min at an 
intensity to elevate HR to 70-75% of HRmax. The moderate exercise group also fulfilled 
ACMS’s recommendations, and their sessions consisted of 20 minutes of continuous walking 
or jogging at an intensity sufficient to elevate HR to 60% of HRmax. The attention-placebo 
group performed strength, mobility and flexibility exercises for each of their sessions and 
also carried out slow, intermittent exercise for at least 30 minutes at an intensity of less than 
50% of HRmax. Later, the subjects in the waiting list group were offered the moderate 
exercise programme.  
 
This above-mentioned study found that positive psychological responses were reported by the 
subjects in the moderate exercise group, but not by those in the high exercise or attention-
placebo groups. This finding was not confined to a single outcome measure, but was 
observed in a number of ratings of mood and perceived coping ability. The authors state that 
it is possible that the participants in the high exercise condition found the training too 
demanding, and that the rigour of the schedule mitigated against any improvements in well-
being. The moderate exercise condition may have been more enjoyable, permitting the 
participants to achieve goals of physical activity that had previously seemed beyond them, 
without exerting undue effort (Moses & Edwards, 1989). These findings are relevant to the 
present study. The authors showed that moderate intensity exercise is a better prescription 
compared to the higher intensity exercise. Participants in the high-intensity group might have 
felt anxious about having to perform at such a demanding intensity, and this may have caused 
them to feel worse if they could not perform or meet the expectations required of them. 
Moderate intensity exercise coincides with ACSM’s recommendations, thus the participants 
in this group probably did not feel pressured to perform at an intensity that was too 
demanding, and they might have been more relaxed and able to meet the requirements.  
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The PANIC/separation-distress system as the ‘missing mechanism’ 
There are considered to be four ‘basic-emotion command systems’ in the human brain, 
namely the SEEKING-, FEAR-, RAGE- and the PANIC/separation-distress system 
(Panksepp, 1998). The PANIC/separation-distress system is built over the physical pain 
pathway in the brain, with the anterior cingulate gyrus as its core (Solms & Turnbull, 2002). 
Stimulation of the PANIC system has even been known to produce a full clinical depression 
(Solms & Turnbull, 2002). The psychological pain that is felt when separation from an 
attachment figure occurs is caused by a withdrawal of endogenous opioids (of which 
endorphins are one type). Therefore, the young animal or human experiences ‘mental pain’ 
upon separation and because this feels bad, learns not to let it happen again (a clear 
evolutionary benefit). Separation distress results in two distinct behaviours. Firstly, the 
animal calls out to be found by its caregiver, which is known as the 'protest phase'. Secondly, 
if the caregiver does not return, then after a while the animal withdraws and waits to be 
found, which is known as the 'despair phase' (Panksepp, 1998). This despair phase behaviour 
is characterized by withdrawal and hiding away from the world, which looks exactly like the 
behavior seen in depression (Solms & Turnbull, 2002).  
 
Rationale 
In periods of prolonged stress and pain from strenuous exercise the body produces chemicals 
called endorphins that help it endure the pain. From an evolutionary point of view this system 
presumably evolved to enable escape from dangerous situations despite one being injured. 
These natural analgesics are only released when the level of pain intensity is at least 
moderately high. The PANIC (separation-distress) system (which seems deeply involved in 
the genesis and maintenance of depression) is built on the same pathways as the pain system. 
The term ‘mental pain’ in the context of feelings of loss is arguably justified in the light of 
this relationship between the physical pain and social loss systems. It is therefore reasonable 
to expect that endorphin release can also affect depressive symptoms in a positive way, as it 
does physical pain.  
 
The available research shows that exercise helps to alleviate depression. Exercise helps lessen 
the effects of depression and also improves mental well-being, mood and health in general. 
The literature suggests that exercise in conjunction with antidepressants has the greatest 
effect on ameliorating depressive symptoms. Thus far, following the guidelines for daily-
recommended energy expenditure (i.e. 30 minutes of an aerobic activity five days per week, 
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or vigorous activity for a minimum of 20 minutes three days per week) seems to be the best 
prescription for overall health and mental well-being. However, the physiological basis (the 
precise mechanism) of the antidepressant effect of exercise has not been fully delineated. The 
exact duration and intensity of exercise required in order to produce a guaranteed β-
endorphin release, and to improve the symptoms of depression, is also still not clear. 
2. AIMS AND HYPOTHESES 
There were two central hypotheses for this study. The first was that the mechanism behind 
the improvements seen in depressive symptoms due to exercise is the same mechanism that is 
responsible for the established analgesic effect of exercise, namely endorphin release. The 
second hypothesis was that only high-intensity exercise (i.e. greater than 70% of heart rate 
reserve) will be sufficient to produce a guaranteed endorphin release, whereas moderate-
intensity exercise (less than 50% of the heart rate reserve) and very low-intensity exercise 
would not be sufficient to release endorphins, and would therefore not result in an 
improvement in depressive symptoms. The main aim was therefore to investigate whether 
intensive exercise improves moderate depression, and if so, whether this correlates with a 
demonstrable increase in β-endorphins.  
 
This study therefore had the following objectives: 
 To determine which of low, moderate or high intensity exercise best alleviate the 
symptoms of depression.  
 To determine whether an increase in β-endorphins correlates to an improvement in 
participants’ depression.  
 To determine whether greater β-endorphin release occurs during high-intensity 
exercise compared to low- and moderate intensity exercise. 
3. METHODOLOGY 
3.1 PARTICIPANTS 
This study focused exclusively on individuals with moderate depression, which was 
determined using an online version of the Major Depression Inventory (MDI) (see Appendix 
A for the questionnaire and scoring criteria), and was then later confirmed by an interview 
with a psychologist using the Hamilton Rating Scale of Depression (HAM-D) (see Appendix 
B). The sample comprised 33 males between the ages of 18 and 42, all of whom were 
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students or staff from the University of Cape Town (UCT). Following the screening process, 
the suitable participants were randomly assigned to one of three exercise/experimental 
groups: High-intensity exercise, Moderate-intensity exercise, or a Control group (very low 
intensity exercise). A total of 21 participants completed the entire six weeks of the exercise 
intervention, and twelve participants (36%) dropped out of the study at some point. From the 
21 participants who finished the study, the High-intensity group consisted of six participants, 
while there were 10 participants in Moderate-intensity group, and five participants in the 
Control group (see Table 1 for baseline characteristics). Among the randomized participants, 
the mean age was 24 years. The 12 participants who dropped out all did so because of their 
demanding schedules; six were in the Control group, two in the Moderate-intensity group and 
four in the High-intensity group. 
 













Age, years 22  26  25  23.8  
BMI, kg/m2 24.7  24.6  33.6  26.8  
 
3.1.1 EXCLUSION CRITERIA 
Females were excluded from this study due to the menstrual cycle. One important 
methodological barrier appears to be that women using hormonal contraception must be 
considered as a separate group for purposes of analysis (Becker, JB, et al. 2005). Any 
individual who had a prior high-intensity exercise routine (i.e. 70% of his heart rate reserve, 
for more than three times per week) was excluded from the study. Any individual whose 
mood was evaluated to be either below, or above, the level of moderate depression was also 
excluded, as was anyone who was already on any form of antidepressant therapy/medication. 
Finally, individuals who had any medical condition (such as coronary heart disease, 
pulmonary disease, metabolic disease, or hypertension, etc.) that put them at risk when doing 
exercise were also excluded (see Appendix E). 
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3.2 MATERIALS 
The following materials were used as part of this study: 
3.2.1 The Hamilton Rating Scale for Depression 
This widely used, diagnostically proven and effective multiple-choice scale was used as an 
external assessment of the severity of depressive symptoms. The Hamilton Rating Scale for 
Depression (HAM-D or HRSD) is required to be administered by a clinician, who interviews 
the participant and then judges the severity of his/her symptoms for each of the 21 items, 
producing a total score (only the first 17 items count towards the total score). Some of the 
items have five possible answers, while others have three. For example, Item 1 is titled: 
‘Depressed Mood’ (sadness, hopeless, helpless, worthless), and has the following score 
allocations:   =  ‘Absent’;   =  ‘These feeling states indicated only on questioning’; 2 = These 
feeling states spontaneously reported verbally’;   = Communicates feeling states non-
verbally — i.e. through facial expression, posture, voice, and tendency to weep’; 4 = Patient 
reports VIRTUALLY ONLY these feeling states in his spontaneous and non-verbal 
communication’. The HAM-D cut-off scores for the different severities of depression are as 
follows: 0-7 = Normal, 8-13 = Mild, 14-18 = Moderate, and 19-22 = Severe (Hamilton, 
1960). The HAM-D is designed to be administered to individuals who have already been 
identified as depressed, with the higher the score, the more severe the depression. This 
questionnaire rates the overall severity of the symptoms that are observed in depression, such 
as low mood, insomnia, agitation, anxiety and weight loss, and is currently one of the most 
commonly used scales for rating depression in medical research.  
 
3.2.2 Montgomery Åsberg Depression Rating Scale (see Appendix C) 
The Montgomery-Åsberg Depression Rating Scale (MADRS) contains ten-items, and is 
primarily designed to measure the severity of depressive episodes. The MADRS is also 
intended to be a supplementary questionnaire for the HAM-D — there is a high degree of 
correlation between scores for the two scales — as it is more sensitive to the changes in level 
of depression than the HAM-D (Montgomery & Asberg, 1979; Heo, Murphy, & Meyers, 
2007). The items on the scale require the clinician examiner to decide, based on interviewing 
the subject, whether his/her response lies on the scale criteria of the MADRS (i.e. a score of 
0, 2, 4 or 6) or between these scores (i.e. a score of 1, 3 or 5) and then to score the response 
accordingly. The MADRS score range for normal/symptom absent is 0 to 6, while Mild 
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depression is a total score of 7 to 19, Moderate depression a score of 20 to 34, and Severe 
depression is a score of >34. Each MADRS item is assessed in terms of the participant’s state 
over the past week (Montgomery & Asberg, 1979). 
3.2.3 Heart Rate Monitor  
A Suunto t6d watch with a chest strap was used in this pilot study. The Suunto t6d heart rate 
monitor was chosen because of its extensive data logging capabilities. This monitor records 
heart rates every 3/100 of a second, which can then be viewed on a graph using the Training 
Manager program. The monitor also records maximum and minimum heart rates (HR) and 
gives an average of both these parameters after each workout. 
3.2.4 DVDs 
Two different television series were offered to the participants so that they could choose to 
watch one of them whilst exercising. Here, each participant watched his desired series while 
he cycled in the lab. Each participant cycled individually. This approach allowed the 
participants to watch a show in order to eliminate possible boredom that they otherwise might 
have experienced while in the lab for a full hour. 
3.2.5 Lode Bike 
For the planned exercise, the participants cycled on a Lode Excalibur Sport Ergometer 
(Groningen Netherlands; V1.52, 1991). This indoor, stationary bicycle was used because the 
resistance in Watts (W) could be externally controlled in order to keep the participants within 
the specific HR zones, as were predetermined for each of the three experimental groups. 
3.2.6 BORG scale 
The BORG scale is a Rating of Perceived Exertion (RPE) scale. The BORG starts at a score 
of six and ends at a score of 20, with six being very, very light exertion and 20 being 
maximum exertion. This scale was used as an indication of how hard the participants felt they 
were working while they were exercising. In this way, the author could tell whether the 
participant was exerting himself too much, or too little, thereby allowing for the set workload 
to be maintained. 
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3.2.7 Peak Sustained Power Output (PSPO) test 
The Peak Sustained Power Output test (PSPO) method of calculating (using the Karvonen 
formula) maximum heart rate (HR) was preferred because it is more accurate than using the 
‘22  mi nus the participant’s age’ approach (Robergs, 2  2 ). Given that there are many other 
equations in the literature that can be used to determine maximum HR, it was felt that a 
cycling-based test was more valid and accurate than the calculation method. An accurate 
maximum HR was required in order to calculate the exact parameters of the HR training 
zones in which the participants would be exercising.  
3.2.8 β-endorphin Analysis 
The first type of kit used to measure the β-endorphin concentrations in the samples was a 
CUSABIO ELISA KIT (catalogue number CSB-E 682 h; hum an β-endorphin, β-EP ELISA 
kit) ordered from Biocom Biotech. This kit produced faulty results and a second, more 
accurate kit by MD Bioproducts was used. This second human β-endorphin kit produced by 
MD Bioproducts is an “Enzyme-linked immunosorbent assay” (ELISA) designed to detect a 
specific peptide and its relative peptides based on the principle of “competitive” enzyme 
immunoassay. The assay protocol was followed as per the manufacturer’s instructions (MD 
Bioproducts division of MD Biosciences, Inc., North America) for the quantitative 
determination of β-endorphins in human serum and plasma samples. The certificate of 
analysis states: sensitivity (0.14 ng/mL), precision (Intra-assay variation <10%, inter-assay 
variation <15%), range (0-100 ng/mL), linear range (0.14-2.3 ng/mL), positive control 
(Rehydrate Positive Control (0.4~0.7ng/mL) with 200µL assay buffer, add in duplicates, 
50µL Standard, Controls and Samples. Blood samples of 3ml were collected into the gold 
Vacutaner tubes, which contain Z Serum Sep Clot Activator.  
 
3.3 DESIGN 
This was a three-armed prospective randomized control pilot study. Each participant was 
randomly assigned to one of three exercise groups  achieved by drawing a number which 
correlated to what group he was placed in. All the participants underwent a six-week exercise 
program involving participation three days per week, for one hour per day (i.e.18 sessions in 
total). This program took place under supervision at the UCT/MRC Research Unit for 
Exercise Science and Sports Medicine (ESSM) at the Sports Science Institute of South Africa 
(SSISA) in Newlands, Cape Town. The High-intensity exercise group exercised on a Lode 
cycle-ergometer at an intensity of 70 to 75 percent of their HR reserve. The Moderate-
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intensity exercise group also exercised on the Lode cycle-ergometer at an intensity of 45 to 
50 percent of their HR reserve, while members of the Control group were required to keep 
their HRs below 120 beats per minute by walking and/or doing very light cycling during their 
exercise session.  
 
Once weekly, the HAM-D and the MADRS interview-based depression questionnaires were 
administered to each participant by a psychologist. Finally, the participants in the High- and 
Moderate-intensity groups each had 5ml of blood drawn, once per week, both before and 
after exercise in order to measure circulating β-endorphin levels and to track any changes in 
these levels over time. The participants in the Control group only had blood samples taken 
twice – once at the start of the study (a baseline measure), both before and after exercise, and 
once on completion of the study, both before and after exercise. 
3.4  DATA ANALYSIS 
The GraphPad Prism version 5.00 for Windows (GraphPad Software, San Diego California 
USA, (www.graphpad.com) was used for statistical analyses. Non-parametric one-way 
ANOVAs with Kruskal-Wallis and Mann-Whitney tests were performed to calculate: (i) 
differences in the HAM-D scores and in the MADRS scores, (ii) circulating β-endorphin 
levels, and (iii) the differences in the heart rates of all three groups’ participants.  
3.4.1 β-endorphin analysis 
The first type of kit used to measure the β-endorphin concentrations in the samples was a 
CUSABIO ELISA KIT (catalogue number CSB-E 682 h; hum an β-endorphin, β-EP ELISA 
kit) ordered from Biocom Biotech, which arrived at the Chemical Pathology Division at the 
University of Cape Town. Several attempts were made to measure the concentration of β-
endorphins in approximately 14 serum samples that had been stored between a few days and 
six months. On each occasion, even though the standards supplied in the kit gave anticipated 
values, the samples were unable to be measured due to the absorbance values being too low 
to read  even lower than the kit buffer. The company concluded that their kit was not 
suitable for the samples being tested (the authors supposes that this meant the samples had 
concentrations of β-endorphins below the detection limit of the kit).  
 
A second kit, manufactured by MD Bioproducts (catalogue number M056011) was then used 
with a greater sensitivity (15.6-10000pg/mL) than the Cusabio kit. Serum samples tested 
- 26 - | P a g e  
 
using the first kit from MD Bioproducts confirmed that this particular ELISA kit was able to 
measure β-endorphin concentrations in the stored serum samples. Unfortunately, the time 
delay after placing the order with Bioco Biotech was several months. This meant that the 
samples were stored for longer that the kit’s validity (stable for one month at -70ºC). In total, 
of the approximately 212 samples, 128 were finally tested using the MD Bioproducts ELISA 
kit (five controls’ samples, six participants’ from the Moderate intensity group, and four 
participants’ from the High-intensity group: each pre-and post-exercise). 
3.5  PROCEDURE 
Advertising for this study was done both through the University of Cape Town’s Monday 
Monthly newspaper and via emails sent to all students on the University database.  
Participants were recruited using an online MDI questionnaire. The suitability of the potential 
participants who were identified as moderately depressed using the MDI, was then confirmed 
by a follow-up interview with a psychologist using the HAM-D  conducted in order to 
further verify this level of depression. Any individuals who were identified as being too 
depressed (severe or major depression) were contacted and offered support. Any potential 
participant with suicidal ideation and/or psychotic thoughts was also excluded from the study 
and help was immediately offered to them. Following the interview, the suitable participants 
were contacted in order to start their exercise sessions. At their first session, all participants 
completed a Health History Questionnaire (See Appendix D) and the study’s Consent Form 
(see Appendix E). Each participant’s height and weight were then recorded, and a 5ml blood 
sample was taken before he started his exercise session. Blood rested in the tube for 30 
minutes after it was collected, and was then centrifuged at 3000 revolutions per minute 
(RPM) for 15 minutes. The plasma was extracted and kept at -80ºC until it was analyzed. 
Blood samples were collected at the UCT/MRC Research Unit for Exercise Science and 
Sports Medicine (ESSM) at the Sports Science Institute of South Africa (SSISA) from 
December 2012 to March 2014. In total, 212 samples were collected and stored at -80ºC, first 
at ESSM, and then later at UCT’s Division of Chemical Pathology for analysis. 
 
Both the High- and the Moderate-exercise groups then did a Peak Sustained Power Output 
(PSPO) test in order to determine their maximum HR in order for the subsequent exercise 
intensity parameters to be calculated. For this test, the participants each wore a heart rate 
monitor and performed a light five-minute warm-up on the Lode cycle-ergometer. This test 
was performed at a starting work rate of 2.0W/kg body mass, after which the load was 
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increased incrementally by 20 Watts each minute until the participant could not sustain a 
cadence greater than 70 RPM. The maximum HR was the highest recorded value at any time 
during the test. If a participant was unable to complete the PSPO test, then the measure of 
220 minus their age was instead used to calculate his maximum HR. After the PSPO test was 
completed, the participants each did their one-hour of cycling in the ESSM lab individually 
within their predetermined HR zones. HR for the entire session was recorded with a heart rate 
monitor, while RPE was recorded using the BORG scale. The HR reserve for individuals in 
the high intensity group was calculated as follows:  (maximum HR   resting heart rate) x 
70%] + resting heart rate. The HR reserve for individuals assigned to the moderate intensity 
group was calculated as follows: [(maximum HR   resting heart rate) x   %     resting heart 
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4. RESULTS 
4.1 Participant drop out 
Three of the 12 participants who dropped out did so after only one session, while the other 
nine completed at least 3 sessions, which allowed for a baseline HAM-D score and an 
additional (final) HAM-D and MADRS score before they dropped out (see Table 2).  
 
Table 2: Depression questionnaire scores in the 21 participants who completes all 18 
sessions 
Group n HAM-D    
initial score 
Mean & (SD)  
HAM-D      
final score 
Mean & (SD) 
MADRS 
initial score 
Mean & (SD) 





6 15.5 (1.5) 4.2 (4.5) 12 (3.7) 5.3 (5.7) 
Moderate 
intensity 
10 16.2 (1.4) 5.7 (4.2) 14 (4.3) 8.1 (6.4) 
Control 5 17.4 (1.3) 9.8 (4.7) 19 (9.2) 13.4 (6.5) 





3 17 (2.4) 8.7 (8.1) 15 (4.5) 10.3 (8.5) 
Moderate 
intensity 
1 18  16 18 18 
Control 5 17 (1.1) 13.8 (1.8) 19 (2.7) 17 (3.4) 
HAM-D code: 0-7 = Normal, 8-13 = Mild, 14-18 = Moderate, 19-22 = Severe 
MADRS code: 0-6 = Normal, 7-19 = Mild, 20-34 = Moderate, >34 = Severe 
 
 
The details of those participants who completed more than a week of the exercise protocol 
before dropping were as follows (Figure 1). In the Control group, two participants completed 
one week (HAM-D score indicated they stayed moderately depressed), two completed one 
and a half weeks (one went from moderate to mild depression and the other stayed at a 
moderate level), one did two and a half weeks (stayed moderately depressed) before dropping 
out of the study. There was only one Moderate-intensity group participant who completed 
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one week before dropping out (he stayed at a Moderate level of depression). In the High-
intensity group, one participant completed four weeks and had no indication of depression at 
the time of dropping out. Two more participants in the High-intensity group only completed 
one week, and one of these went from moderate to mild depression before he dropped out. 
The severity of depression of the participants who dropped out is shown in Figure 2. All 
those who dropped out informed the author through writing that they wished to drop out of 


















Figure 1.  HAM-D and MADRS scores for participants who dropped.                                                 
A.) Shows, for all three groups, the average initial and final HAM-D scores for the participants who 
dropped out of the study. B.) shows the average initial and final score of the MADRS before dropping out. 












4.2 EXPERIMENTAL PARTICIPANTS: Heart Rate ranges 
The heart-rate range for the High-intensity group was 70 to 75% of their HR reserve. All six 
participants exercised within this range or close to it. These participants cycled at intensities 
of between 100-180 Watts, and their PRE was between 13 and 19 on the Borg scale. The ten 
Moderate-intensity group participants had to exercise at 45 to 50% of HR reserve. These 
participants cycled at intensities between 80-100 Watts on the Lode cycle-ergometer, while 
their RPE was between 7 and 12 on the Borg scale. The five Control group participants 
engaged in very light exercise by cycling on the Lode cycle-ergometer at 60 Watts at 50-60 
RPM, and/or by walking on an indoor walking track (± 70m in circumference). These Control 
group participants were instructed not to exceed 120 beats per minute (bpm) while they 
exercised, and their average heart rate for each session did not exceed 120 bpm (with the 
exception of two participants whose average heart rates were 124 bpm and 122 bpm, 
respectively). However, this did not cause these two participants to cross over into the 
moderate-intensity range. Figure 3 shows the average heart rate ranges for each session. The 
High-intensity group had the highest heart rates between 150-160 bpm. The Moderate-
Figure 2. Severity of depression for participants who dropped out of the study. The overall results 
and severity of depression after completing at least one week of the study (based on the HAM-D from 
the initial to final scores). 
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intensity group was in the middle with heart rates between 130-140 bpm, while the Control 
group had the lowest heart rates at 120 bpm and under.  
When analyzed, the three experimental groups’ average heart rates per exercise session 
throughout the six weeks of exercise were significantly different. When comparing individual 
sessions, there were no significant differences between the Moderate- and Control groups 
during sessions 1, 2, 8, 9, and 17, but for the other sessions (3-7, 10-16, and 18) there was a 
significant difference between these two groups. There was a significant difference between 
the High-intensity- and Control groups over all 18 sessions (see Figure 3). Overall, the 
participants were able to exercise in their prescribed intensities for the majority of the 
sessions, and all three experimental groups were significantly different in terms of their heart 
rate ranges (p = <0.0001) due to the different exercise intensities (see Figure 4). Figure 5 




Figure 3. Average heart rate per exercise session for each group over six weeks (18 sessions).                       
*Sessions significantly different between Moderate- and Control groups.  **Significant difference 
between the High-intensity- and the Control group for all 18 sessions (p = <0.0001).  *** All three 
groups’ average HRs were significantly different (p =  .    ) .                                                                                          
 



























Figur4.Average heart rates.                                                                                                                  
Shows the average heart rates for all three exercising groups. The High-intensity group had an average 
HR of 153 bpm. The Moderate-intensity group’s average HR was   2 bpm  and the Control group’s was 
116 bpm. There was a significant difference between all three groups based on the average heart rates 
achieved in all 18 sessions, p = <0.0001. No SD values are reported since we used non parametric 
statistics. 
Figure 5. Average heart rate per participant for all three groups over 6 weeks (18 sessions). 
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4.3 Psychological data 
The HAM-D and the MADRS were completed through an interview by all participants, once 
weekly, for a total of six times (see Table 2). The High- and Moderate-intensity groups 
showed greater improvement in their depression scores over the six-week exercise 
intervention. All participants were moderately depressed at the start of the study. Figure 6 
shows a box and whiskers diagram displaying all three groups’ HAM-D scores prior to 
starting the exercise intervention, as well as posts the exercise intervention after six weeks. 
Both the Moderate- and High-intensity groups showed improvement in their HAM-D scores, 
while the Control group also improved, but not as much as the other two groups. There was 
no significant difference when comparing all three groups’ initial HAM-D scores (p =0.0789) 
with each other, or when comparing their final HAM-D scores (p =0.0974). However, there 
was a significant difference (p = < 0.0001) when comparing the initial scores for each group 
to their final HAM-D scores. In examining the individual groups’ HAM-D scores, there is a 
significant difference (p = 0.0048) for the High-intensity group when comparing their initial 
and final scores. The Moderate-intensity group also showed a significant difference between 
their initial and final HAM-D scores (p=0.0002). The same trend was apparent for the 
Control group, although not quite as significant as for the other two groups (p=0.0160). 
 
Figure 7 shows how the High-intensity group (n=6) had five participants with no depression, 
and one participant with mild depression after the 18-session intervention. The Moderate-
intensity group (n=10) had six participants with no depression, and four participants had mild 
depression after the 18-session intervention. The Control group (n=5) had one participant stay 
at moderate depression (i.e. no change), one with no depression, and three participants with 
mild depression after the 18-session intervention. In all three experimental groups, none of 
the participants increased from moderate to severe or major depression. These findings show 
that all three interventions were effective, to some extent at least, for all but one participant.  
 
The MADRS was also used to measure the severity of depression in each participant, with the 
results for this questionnaire displayed in Figure 8. There was no significant difference when 
comparing all three groups’ initial MADRS scores (p =  .26  ) , or when comparing their 
final MADRS scores (p = 0.1596). However, there was a significant difference (p = 0.0182) 
when comparing the initial scores within each group to the final MADRS scores. The High-
and Moderate-intensity groups showed a significant difference between their initial and final 
scores (p = 0.0450) and (p = 0.0340) respectively. The Control group did not show a 
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significant difference between their initial and final scores (p = 0.3443). When comparing the 
final MADRS scores between the High-and Moderate-intensity groups there was not a 
significant difference (p = 0.4139), nor was there when comparing the final scores between 


















Figure 6. Box and whiskers indicating the initial and final HAM-D scores for all three 
exercising groups. The High-intensity group’s average HAM-D scores improved from 15.5 to 4.2. 
The Moderate-intensity group’s average scores improved from  6.2 t o  .7. The Control group 
improved from 17.4 to 9.8 in their average HAM-D scores. All three experimental groups showed an 
improvement in their HAM-D scores, and there was a significant difference between the initial and 
final scores (p = <0.0001). 



















Figure 7. Overall results and severity of depression at the end of 6 weeks. Overall results for the 
HAM-D after six weeks of exercise at various intensities. The High-intensity group had five participants 
improve from a moderate level of depression to no depression, and one participant improved from a 
moderate to a mild level of depression. The Moderate-intensity group had six participants improve from a 
moderate level of depression to no depression, and four improve from a moderate to mild level of 
depression. In the Control group, one participant improved from a moderate level of depression to no 
depression, while three participants improved from a moderate to mild level of depression, and one 
participant showed no change (i.e. he stayed at the moderate level of depression). 
Figure 8.  MADRS scores.   
Shows the initial and final MADRS scores, which indicates the severity of depression. Both the 
Moderate- and High-intensity groups showed lower scores than the control group did, with the High-
intensity group having the lowest (the lowest level of depression). All three groups showed a 
statistically significant difference between their initial and final scores (p = 0.0182). No SD values are 
reported since we used non parametric statistics. 
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4.4 β-endorphin  
Figure 9A shows the mean circulating β-endorphin levels for each week between the 
Moderate- and High-intensity groups. Figure 9B shows the relationship between the 
individual heart rate achieved and the serum β-endorphins concentrations obtained in any 
particular session (once per week, for six weeks) for both the Moderate- and the High-
intensity groups – here, no clear relationship was found.  
 
There was a significant difference (p = 0.0222) in the post-exercise concentrations of β-
endorphin (see Table 3) amongst the Control, Moderate- and High-intensity groups. When 
comparing the post exercise β-endorphin values of the Control group to the Moderate-
intensity group, a significant difference of p = 0.0173 was found. On the other hand, when 
comparing the post exercise β-endorphin values of the Control to the High-intensity group, 
there was no significant difference (p = 0.0856). Since the β-endorphin levels in the Control 
group decreased throughout the six-week intervention, unlike the other two groups whose β-
endorphins did not decrease, it could be concluded that low-intensity exercise does not yield 
an endorphin release.  
 
Each of the Control group participants (with the exception of one participant for one visit) 
showed a significant decrease in their β-endorphin concentrations after exercise (Table 4), 
whereas there were an almost equal number of increased and decreased values for those 
within the Moderate-intensity exercise group (see Table 4). The High-intensity group 
participants showed a slightly greater number of decreased values for β-endorphin 
concentrations over all their sessions. The mean values after exercise for both the Moderate-
and High-intensity groups were not significantly different to their baseline values (see Table 
5). The differences between the baseline and post-exercise measurements were also not 
significantly different for both the Moderate- and High-intensity groups (p = 0.953 and p = 










































Figure 9. Beta-endorphin levels for Moderate- and High-intensity groups.                          
A.) Shows the β-endorphin levels for the Moderate- and High-intensity groups each week.                
B.) Shows that there was no relationship between the heart rate and the β-endorphin levels for both 
the Moderate- and High-intensity groups, indicated with linear regression lines.  
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 CON PRE CON POST MOD PRE MOD POST HIGH PRE HIGH POST 
Number of values 8 8 30 30 24 24 
             
Minimum 0.6400 0.2520 0.5350 0.5180 0.6340 0.4930 
25% Percentile 0.7823 0.4910 0.8315 0.8163 0.8333 0.8220 
Median 1.103 0.7320 1.039 1.001 0.9205 0.9530 
75% Percentile 1.661 0.9480 1.145 1.164 1.027 1.028 
Maximum 1.866 1.272 2.241 2.465 1.148 1.245 
             
Mean 1.196 0.7370 1.087 1.082 0.9190 0.9059 
Std. Deviation 0.4530 0.3187 0.4080 0.3878 0.1278 0.1709 
Std. Error 0.1602 0.1127 0.07449 0.07080 0.02609 0.03489 
             
Lower 95% CI of mean 0.8175 0.4706 0.9346 0.9367 0.8650 0.8337 
Upper 95% CI of mean 1.575 1.003 1.239 1.226 0.9729 0.9781 
             
Sum 9.570 5.896 32.61 32.45 22.06 21.74 
                                                                                  P = 0.159 
 













Table 3. Results of column statistics for measurement of serum β-endorphin concentrations 
within the three experimental groups, before and after exercise. Non-parametric ANOVA 
(Kruskal-Wallis) statistics when analyzing all three groups’ pre-exercise measures showed p = 0.159, 
while the post-exercise measures showed a significant difference of p = 0.022. When comparing the 
MOD- versus the CON group, p = 0.0173, while when comparing the HIGH- versus the CON group, 
p = 0.0856. When comparing the MOD- versus the HIGH group, p = 0.0896. 














0.741 0.470  0.271 1.047 1.074 -0.027 0.843 1.030 -0.187 
0.640 0.252  0.388 1.031 1.091 -0.060 0.767 0.843 -0.076 
1.495 0.954  0.541 1.153 1.071  0.082 0.792 0.857 -0.065 
1.175 0.741  0.434 1.018 1.273 -0.255 0.830 1.035 -0.205 
1.866 1.272  0.594 0.996 1.156 -0.160 1.012 0.993  0.019 
1.716 0.723  0.993 2.241 2.465 -0.224 0.877 0.950 -0.073 
1.031 0.554  0.477 2.212 1.865  0.347 0.928 0.995 -0.067 
0.906 0.930 -0.024 1.998 1.699  0.299 0.857 0.974 -0.117 
      0.809 0.788  0.021 0.913 0.780  0.133 
      0.781 0.797 -0.016 0.807 0.659  0.148 
      0.710 0.674  0.036 0.734 0.493  0.241 
      0.535 0.518  0.017 0.964 1.245 -0.281 
      1.098 0.814  0.284 0.976 0.867  0.109 
      0.593 0.736 -0.143 1.051 1.050  0.001 
      1.223 0.933  0.290 0.881 0.889 -0.008 
      0.854 0.814  0.040 0.862 0.872 -0.010 
      0.793 0.817 -0.024 0.930 0.815  0.115 
      0.849 0.894 -0.045 0.967 0.956  0.011 
      0.839 0.871 -0.032 0.634 0.586  0.048 
      0.783 1.115 -0.332 1.148 0.706  0.442 
      1.223 1.467 -0.244 1.128 1.021  0.107 
      1.303 1.339 -0.036 1.088 1.083  0.005 
      1.135 1.188 -0.053 1.032 1.000  0.032 
      0.944 0.976 -0.032 1.034 1.043 -0.009 
      1.096 1.048  0.048       
      1.064 0.999  0.065       
      1.142 1.003  0.139       
      1.132 0.999  0.133       
      1.141 1.132  0.009       











P = 0.0010 
Dunn Post Hoc-test: 
CON vs LOW P <0.05** 
CON vs HIGH P <0.05** 
Table 4. Results of individual changes within the three experimental groups, before and after 
exercise. A positive value indicates a decrease. Non-parametric ANOVA (Kruskal-Wallis) statistics 
when comparing the changes in all three groups were p = 0.0010. A Dunn Post Hoc-test comparing 
the Control- versus the Moderate-intensity group, p <0.05, and the Control- versus the High-intensity 
group, p = <0.05.  





        CON  
    post mean 
  MOD  
pre mean 
   MOD  
post mean 
  HIGH  
pre mean 
   HIGH  
post mean 
0.691 0.361   1.049    1.133    0.854    0.951 
1.495 0.954   2.150    2.010    0.867    0.858 
1.521 1.007   0.709    0.694    0.945    0.908 
1.716 0.723   0.902    0.835    1.011    0.907 
0.969 0.742   1.038    1.159     
      1.073    1.002     
 







Table 5. Results of pooled data and other statistical analyses for measurement of serum 
β-endorphin concentrations for all three groups. A Paired-t test indicates there was a 
significant difference when comparing the Control groups’ mean pre-and post-exercise values 
p=0.017. Both the Moderate-and High-intensity groups’ mean pre-and post-exercise values 
were not significant, p=0.734 and p=0.772. 
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5. DISCUSSION 
All the participants exercised within their assigned heart rate ranges throughout the six weeks 
of the study. All three of the experimental groups were significantly different in terms of their 
average heart rates achieved per session (p = < 0.05). This indicates that there was no overlap 
between the experimental groups, and that the participants exercised within their required 
heart rate ranges (70%, 50%, or < 30% of HR reserve). This also indicates that it is possible 
to implement a structured exercise routine for individuals with depression who are generally 
unfit. 
 
Due to the fact that there were a number of sessions (1,2,8, 9 and 17) where there were no 
significant difference between the Moderate- and Control groups’ heart-rate ranges, it can be 
inferred that for their first and second sessions, the participants might not have known what to 
expect and they may have been nervous, which therefore might have caused them to over-
perform. As the weeks went on, the participants seemed to become more comfortable with 
the study’s procedure and routine, so they performed within the parameters of the prescribed 
heart-rate intensities. It is not clear why there was no significant difference between the 
Moderate- and Control groups in sessions 8, 9 and 17. Perhaps this was because there were 
two participants in the Control group who failed to maintain a low heart rate (not exceeding 
120 bpm) during a number of their sessions. 
 
Some of the participants (potentially those in all three groups) may have experienced training 
adaptations. Throughout the study, the workloads at which the High- and Moderate-intensity 
groups were cycling had to be increased in order to maintain the heart-rate range that they 
were prescribed. As the participants became more familiar with the training, and their bodies 
adapted to the workload, the workloads had to be increased in order for their heart rates to 
remain within the specified range. Although most of the participants were inactive prior to 
starting the study, it can be assumed that most experienced changes or adaptations in 
physiological function in response to the repeated series of exercise intervention. Typically, 
most untrained individuals can expect between a 10% to 30% improvement in VO2 peak and 
work capacity following an eight-to-12 week period of training (American College of Sports 
Medicine, 2011). Although the present study did not measure VO2 max, this would have been 
a more accurate measure of assessing whether the participants underwent any exercise 
adaptations or fitness gains. 
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5.1 Depression scores 
In order to determine which exercise intensity/intensities alleviated the symptoms of 
depression, all the participants completed a HAM-D and MADRS questionnaire on a weekly 
basis. Overall, the participants’ HAM-D scores after six weeks of exercise were reduced 77% 
from baseline for the High- intensity group, significantly more than the Moderate-intensity 
group (65%) and the Control group (44%). The MADRS scores also improved after six 
weeks of exercise. The High-intensity group’s MADRS scores reduced  8%  from baseline 
and the Moderate-intensity group showed an improvement of 43% and the Control group 
24%.     
 
Based on the HAM-D and MADRS scores, the High-intensity group showed the greatest 
improvement, with a reduction of 77% over the six-week period, which was significantly 
better than the Control group. This indicated that the participants in the High-intensity group 
experienced a better response to the high-intensity exercise, which in turn increased their 
mood states. However, all of the experimental groups showed improvement in their HAM-D 
scores at the end of the six weeks. This finding goes against the study’s hypothesis that only 
the High-intensity group participants would improve their level of depression. Given that 
some of the Control’s also showed some small improvement in their level of depression, it 
has to be concluded that other variables were also responsible for the improvements see, such 
as a positive psychological boost experienced from participating in an exercise programme 
perceived as resulting in self-improvement, and the possibility of spontaneous recovery in 
some of the participants. In order to avoid the possibility of social support influencing 
treatment response, all the participants exercised in a lab by themselves, supervised only by 
the project leader. Every Friday, the study’s psychologist interviewed the participants and 
completed the HAM-D with them. It is thus possible that the attention that the participants 
received from the psychologist each week may have had a minor therapeutic effect (although 
this would not have favoured any of the three experimental groups in particular). Finally, 
given that lack of motivation and lethargy characterize depression, having a structured 
exercise program for six weeks may have also counteracted these characteristics to some 
extent. Motivation was important, especially during the first week of the study, which 
presumably acted as a trial period for the participants, making or breaking their drive to 
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continue. When sessions were missed, the participant was contacted immediately to ensure 
that he was okay, and was then encouraged to try to make it to his next appointment.  
 
These above-mentioned findings also answer the question of which exercise intensities were 
able to alleviate the symptoms of depression, and it is clear that overall both high- and 
moderate-intensity exercise produced meaningful improvements in depressive symptoms 
(evident through the reductions in the HAM-D and MADRS scores). Low-intensity exercise 
(<30% HR reserve) also showed improvements, but not as greatly as for the high-and 
moderate-intensities. All of the High-intensity groups’ participants improved in their HAM-D 
scores as well as their MADRS scores. Within the Moderate-intensity group, all the 
participants’ HAM-D scores improved, and all but one of the participants’ MADRS scores 
improved. This one participant’s MADRS score was initially  6 a nd at the end of the six 
weeks it worsened to 20. This indicated that his level of depression increased. The Control 
participants HAM-D scores all also improved, as did their MADRS scores (with the 
exception of one participant, who’s score went from a 22 to 2 ). The fact that overall the 
individuals in the High-intensity group improved relatively more in terms of their level of 
depression (when observing where they had improved to by the end of the six weeks) needs 
to be seen in relation to the study’s β-endorphin results (see below). Given the small sample 
size of this pilot study, and the fact that the experimental groups were not even in size, these 
results must be viewed tentatively, and it would be interesting to see whether a larger sample 
size would yield different results between the High- and Moderate-intensity groups with 
regard to their improvements in level of depression. 
 
The reduction in level of depression displayed in the present study is comparable to the 
results of Dunn and co-workers (2005), which showed that the high-energy expenditure dose 
(consistent with public health recommendations) was effective in reducing depressive 
symptoms (47% from baseline measurement) over a 12-week treatment period. Although 
those randomized into the low energy expenditure dose did experience some reduction in 
depression over the 12-week period (30% from baseline measurement), they did not respond 
significantly better than the control condition (29% from baseline measurement) (Dunn et al., 
2005). In younger adults, a previous investigation examined whether daily activity and the 
tendency to participate in exercise were associated with mood states in a student cohort. The 
results showed that mood tended to be higher on the day an individual exercised, and that 
daily activity and exercise overall are strongly linked with mood states. In line with these 
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findings, a recent study showed that exercise significantly improves mood states in non-
exercisers, recreational exercisers, as well as marathon runners (Dinas et al., 2011). 
Therefore, consistent with the literature, the results of this pilot study indicate how all three 
exercise groups showed improvement in their HAM-D and MADRS scores at the end of the 




It was predicted that a β-endorphin release would only occur during high-intensity exercise, 
and not with low- and moderate-intensity exercise. This hypothesis was disproven in that 
there was no significant difference found between the baseline and post-exercise serum β-
endorphin levels in the High-intensity group (p = 0.992). No difference was found in the 
Moderate-intensity exercise group either (p = 0.953). There were an almost equal number of 
increased and decreased values for those in the Moderate-intensity group (with only two 
participants exhibiting an increase at almost every visit). Surprisingly, the High-intensity 
group showed a slightly greater number of decreased values for β-endorphin concentration at 
all the visits (with only one subject showing an increase at every session, save for one). The 
mean values after exercise for both the Moderate- and the High-intensity groups were not 
significantly different to the baseline values. The finding of a significant difference in post-
exercise concentration of β-endorphin amongst the Controls, and the Moderate- and High-
intensity groups (with a p <0.02 for the Controls versus the Low-intensity group) is probably 
not meaningful in the context of this study’s small sample size. Interestingly, each of the 
Control group participants (with the exception of one during one of his sessions) showed a 
significant decrease in β-endorphin concentrations following exercise. The Control group’s 
values of absolute change (even though they decreased after exercise) were greater than the 
changes for the Moderate- and the High-intensity groups’ values.  
 
These above-mentioned β-endorphin results are surprising, inconsistent and inconclusive. 
However, these unpredicted results can most likely be explained by the problems encountered 
with the ELISA kits and the various reasons (see the ‘Limitations’ section below) why they 
were unable to detect possible increases meaningfully. Despite these findings, inferences can 
still be made regarding the release of endorphins in relation to the intensity of exercise and 
the possibility for improvements in depressed mood, as the High-intensity group clearly 
experienced the greatest overall improvement in their depression levels, so it may be that 
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elevated brain endorphin levels could account for this trend even though conclusive 
elevations could not be demonstrated in the circulation due to the limitations of the testing 
methods. In addition, the Control group’s circulating β-endorphin levels did not improve 
throughout the study (but rather decreased), indicating that exercising at <30% of maximum 
heart rate is not enough to produce a β-endorphin release.  
 
Other exercise-based studies indicate that the release of β-endorphins is dependent more on 
the relative, than the absolute, amount of exercise, and that exercise intensities of at least 70 
percent of VO2max must be reached before the plasma level of β-endorphin increases 
(Øktedalen et al., 2001). In comparison, there were no differences in serum β-endorphin 
levels in the present study’s Moderate- and High-intensity groups. It appears as though there 
was a slight increase in the Moderate-intensity group’s serum β-endorphin levels in the 
middle of the intervention versus those of the High-intensity group, but not enough to be 
significant (see Figure 9). It is not clear why there was no significantly higher increase in β-
endorphins in the High-intensity group compared to the Moderate-intensity group, other than 
surmising that is this due to the problem of having to measure β-endorphins through the 
blood. There is also the possibility that the participants in the High-intensity group felt 
pressured to perform at such a vigorous intensity and that it was too demanding, and this may 
therefore have caused angst among them, although this was not reported by any of the 
participants when interviewed on a weekly basis. 
 
A review by Goldfarb and co-workers (1997) suggests that exercise-induced β-endorphin 
alterations in the circulation are related to the type of exercise and the special populations 
tested, and may differ in individuals with health problems. Some of the possible mechanisms 
that may induce β-endorphin changes in blood circulation include analgesia, lactate or base 
excess, and metabolic factors. Based on the type of exercise, different mechanisms may be 
involved in the regulation of β-endorphin release during exercise (Goldfarb et al., 1997). 
Measuring circulating β-endorphins may be more difficult than perceived due to other 
metabolic and mechanistic factors not known. According to Schwarz and colleges, intense 
endurance exercise performed at lactate steady-state leads to an increase in β-endorphins only 
beyond an exercise duration of approximately one hour, so that during endurance training in 
leisure-time sports or healthy sporting activities, no increase in β-endorphins is generally 
expected. However, in long-lasting endurance exercise (such as long-distance running) an 
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increase in endogenous opioids, and concomitant endorphinergic effects (such as changes in 
mood state), can be assumed (Schwarz & Kindermann, 1992).  
 
Another study by Schwarz & Kindermann (1990) concluded that exercise involving 
anaerobic components increases β-endorphin and lactate levels more profoundly. It is also 
possible that a longer intervention of eight to 12 weeks may have yielded more favourable 
results. However, a systemic review by Krogh and co-workers (2011) examined the 
effectiveness of exercise in adults with clinical depression and found that within the 13 trials 
that fulfilled their inclusion criteria, there was evidence that those with a shorter intervention 
(less than 10 weeks) had a stronger beneficial effect than those trials in which the duration of 
the intervention was longer (Krogh et al., 2011). There is a large amount of literature that 
supports the belief that physical exercise has on increasing circulating β-endorphin levels, but 
there is also controversial evidence; for instance, in a study done on eight healthy volunteers 
who had to exercise for one hour, no elevation of circulating β-endorphin levels was reached 
after 20 or 60 minutes (Elias et al., 1986). The same authors observed an elevation in 
circulating β-endorphins in exercise-trained participants, but these raised levels returned to 
normal 60 minutes after physical activity (Elias et al., 1989). A study conducted by 
Langenfeld et al. (1987) found no increase in β-endorphin levels after exercise (bicycle 
ergometer and treadmill) testing at 60% VO2 max. Consistent with this finding, Rahkila et al. 
(1988) observed that endorphin-secretion into the circulating is stimulated only by relatively 
strenuous physical activity.  
 
5.3 Frequency of exercise 
There has not been much research on the effect that exercise frequency has on lowering 
depression scores. It would seem that the more frequently someone exercises, the greater the 
improvement in his/her depression might be. Dunn and co-workers (2005) found that there 
was no significant difference in treatment response between participants who exercised for 
three days per week relative to those who exercised for five days per week. In conclusion, 
high energy expenditure dose (consistent with public health recommendations for energy 
expenditure) is recommended for remission of major depressive disorder in previously 
sedentary adults, regardless of the number of days of exercise per week (Dunn, et al., 2005). 
All the participants in the present study followed the protocol, which required them to come 
in for testing three times per week. On some occasions, a participant might have been ill and 
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missed a session or two, but overall they were eager to continue as soon as possible in order 
to meet the required total of 18 completed sessions.  
6. LIMITATIONS  
This pilot study’s small sample size, and its uneven group sizes with respect to those who 
completed, limit the ability to comprehensively determine whether there might have been a 
greater difference noticed between the Moderate-and High intensity-groups’ improvements in 
depressed mood. Despite this, from a qualitative perspective, consistent and meaningful 
differences were nonetheless found between the High- and Moderate-intensity groups. In any 
event, it would have been logistically very difficult to derive a larger sample size given the 
time that it takes to put one participant through the six-week programme, and the restrictions 
on the number of individuals that can be seen per week due to the limited amount of the 
equipment that is required, the fact that the participants exercised individually, and the 
amount of man-hours required to see each participant. Future studies must bear these 
logistical restrictions in mind. 
 
The extent to which the study’s volunteer participants are representative of the general 
population of depressed individuals is also somewhat uncertain, although these were 
individuals who were in the main not seeking treatment actively for their depression prior to 
enrolling in this study, and their motivation levels were found to be low during the study, so 
it is unlikely that they were unrepresentative in this regard.  
 
This study also had a number of problems concerning the measurement of the participants’ β-
endorphin levels, which potentially led to the strange and inconclusive results that were 
observed. In order to measure these levels, blood/serum samples were used. It is known in the 
literature that measuring serum β-endorphins levels is problematic, and it is not clear how 
effective this method is, nor how accurate it is in terms of representing the total amount of 
centrally circulating endorphins (i.e. those in the brain) (Schwarz & Kindermann, 1992) 
(Meyer & Schwarz, 1975). A more accurate means of measuring β-endorphins would be to 
measure levels in the brain, however this is not possible during exercise. We also encountered 
problems with the first kit type that was used to analyze the β-endorphins in the first ten 
participants. Another potential limitation might be the time the samples were kept in the 
freezer before analysis. It would have been best to test the samples on a monthly basis, and it 
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could be speculated that the samples were kept in freezers too long before being analyzed due 
to the waiting period between ordering new kits. However, various logistical realities make 
getting around these problems very difficult in realty for any study. These realities include: 
(i) the delays caused between ordering and receiving kits; (ii) the need to experiment with 
various kits first to ensure that they are effective in detecting β-endorphin; and the limited 
time one has to use the kit before it expires versus the amount of time it takes to collect 
enough blood samples to analyze. It is unclear how one would avoid these logistical realities.  
 
Encouragement was also given to the participants to continue with exercise after they 
completed the study, but it is not known whether they took this advice. These findings are 
consistent with and extend previous studies by showing a specific association between 
(aerobic) exercise within the range of >50% of HR reserve and decreased prevalence of 
depressive symptoms.  
   
7. CONCLUSION 
This study’s central hypothesis was disproved in that both High- and Moderate-intensity 
exercise were shown to have a positive impact on alleviating the symptoms of moderate 
depression, whereas it was initially believed that only high-intensity exercise would be 
sufficient to produce a β-endorphin release. The exercise intensity that is sufficient in 
alleviating depression appears to be in the range between moderate (50% of heart rate 
reserve) and high (>70% heart rate reserve) intensity, while lower-intensity exercise does not 
appear to be as effective. This study therefore supports the literature in showing that exercise 
is useful for the treatment of depression. However, β-endorphin values did not increase in a 
significant manner during exercise in the High- and Moderate-intensity groups. Given the 
problems encountered with the ELISA analysis kits, the acknowledged difficulty with 
measuring β-endorphins in the blood, and the lack of significant differences with respect to 
the Moderate- and High-intensity groups’ serum β-endorphin levels, this study cannot 
conclusively prove the hypothesis regarding the mechanism underlying the benefit of 
exercise on the symptoms of depression; namely, involvement of the PANIC/separation-
distress system.  
 
Future studies are required to replicate these findings in a larger sample (> 45 participants) 
and to address the problems associated with measuring serum β-endorphin levels. 
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8. APPENDICES 
Appendix A: MDI 
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Appendix B: Hamilton Rating Scale of Depression (HAMD)   
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Appendix C: Montgomery Åsberg Depression Rating Scale (MADRS) 
 
- 57 - | P a g e  
 
Appendix D: Health and History Questionnaire 
 
SWEATING AWAY DEPRESSION? 
THE IMPACT OF INTENSIVE EXERCISE ON DEPRESSION 




Name:           _______ 
Surname:            
Date of birth:        Age:     
Gender:          
Postal address:            
         Code:     
Email address:            
Phone number:  (w)           (h)      
Cell phone:          
Weight:         (kg) 
Height:         (cm)  
BMI:          
Body fat:        (%) 
Blood pressure:        (mm Hg) 
LIFESTYLE HABITS - 
Occupation/Degree (and level) registered for:         
Do you smoke? (number per day):        
   
Have you ever smoked? (number per day):       
  
What is your typical alcohol consumption? (units/day):         
Do you use recreational drugs? (type/amount/frequency):     _______ 
Have you ever used them? (type/amount/frequency):        
_______________________________________________________________________ 
The University of Cape Town is committed to policies of equal opportunity and affirmative action which 
are essential to its mission of promoting critical inquiry and scholarship 
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MEDICAL HISTORY 
Are you aware of, have you ever suffered from, or have you been diagnosed as being at risk of 
circulatory or peripheral vascular disease, or coronary artery disease due to factors such as 
high blood cholesterol, a family member with heart disease, cigarette smoking, lack of physical 
activity, hypertension (high blood pressure), or being overweight? 
yes no 
If yes, please specify which factor(s) and/or disease, and provide details: 
 
Have you previously suffered from, or have you ever been diagnosed with a heart or blood 
vessel condition, such as a heart attack, angina (chest pain), cardiac failure, cardiac 
arrhythmia (abnormal heart beat), rheumatic fever, heart murmur or an inherited heart defect? 
yes no 
Have you ever undergone a coronary artery bypass operation, angioplasty, cardiac transplant, 
or have to make use of a pacemaker? 
yes no 
If yes, please specify which condition(s), and provide details: 
Do you currently experience any symptom(s) of a heart or blood vessel condition, such as 
swollen ankles, abnormal shortness of breath (with exercise), palpitations, chest pain, pain (or 
discomfort) in the neck, jaw or arms at rest or during exercise, frequent dizziness or fainting 
spells, and/or calf pain when walking/running? 
yes no 
If yes, please specify which symptom(s), and provide details: 
Do you currently suffer from any metabolic or hormonal disease or condition, such as diabetes 
mellitus (insulin-dependent or non-insulin-dependent), thyroid gland disorders, hypoglycaemia 
(low blood sugar), hyperglycaemia (high blood sugar), heat intolerance, malignant 
hyperthermia, or an underlying metabolic muscle abnormality? 
yes no 
Have you ever suffered from any abnormal thermoregulatory response specifically to exercise, 
such as heat illness, rhabdomyolysis, renal failure or exercise-induced heatstroke? 
yes no 
If yes, please specify which disease and/or condition, and provide details: 
Do you suffer from any respiratory (lung) disease or symptom(s), such as asthma, emphysema, 
tuberculosis, wheezing, coughing, postnasal drip, hay fever, or repeated flu-like illness? 
yes no 
If yes, please specify which disease and/or symptom(s), and provide details: 
 
Do you suffer from any allergies, or have a history of allergic reactions to medication, plant 
material and/or animal material? 
yes no 
If yes, please specify which allergy, and provide details: 
Do you suffer from any gastrointestinal disease or symptom(s), such as heartburn, nausea, 
vomiting, abdominal pain, weight loss or gain (> 5kg), a change in bowel habits, chronic 
yes no 
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diarrhea, blood in the stools, or have a past history of liver or gallbladder disease? 
Have you ever undergone gastrointestinal (GI) tract surgery, or have been diagnosed with a 
known or suspected obstructive disease of the GI tract, an inadequate gag reflex, felinization of 
the oesophagus,  or polyps in the colon, or have a hypermotility disorder of the GI tract? 
yes no 
If yes, please specify which disease and/or symptom(s), and provide details: 
 
 
Do you suffer from any disease or symptom(s) of the central nervous system, such as a past 
history of stroke or transient ischaemic attack (a transient episode of neurologic dysfunction 
caused by loss of blood flow), frequent headaches, epilepsy, depression, anxiety attacks, 
muscle weakness, nerve tingling, loss of sensation, or blackouts/fainting? 
yes no 
If yes, please specify which disease and/or symptom(s), and provide details: 
Do you suffer from any disease or symptom(s) of the kidney or bladder, such as a past history 
of kidney or bladder disease, blood in the urine, loin pain, kidney stones, frequent urination, 
or burning during urination?  
yes no 
If yes, please specify which disease and/or symptom(s), and provide details: 
Do you suffer from any disease of the blood or immune system, such as anaemia, recurrent 
infections, HIV/AIDS, leukemia, or are you using any immunosuppressive medication(s)? 
yes no 
If yes, please specify which disease, and provide details: 
Do you suffer from any growths or cancer, or have a history of cancer? yes no 
If yes, please specify which type of cancer, and provide details: 
Do you have a history of sudden death in your family, under the age of 60 years? yes no 
Do you suffer from chronic fatigue syndrome? yes no 
Do you suffer from arthritis, gout, neck-, back- or joint pain, or any other musculoskeletal 
disorder? 
yes no 
If yes, please provide details: 
Do you suffer from any other medical condition(s), or experience any other significant 
symptoms which you are concerned about? 
yes no 
If yes, please provide details: 
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What medication, if any, are you currently using (acute and/or chronic) 
Name of medication and duration of use: 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  _ _ 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  _ _ 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  
What dietary supplements/ vitamins, if any, are you currently using? 
Name of supplement and duration of use: 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  _ _ 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  _ _  
Have you ever suffered from muscle cramping (painful, spontaneous, sustained spasms of a 
muscle) during or immediately (within 6 hours) after an activity? 
yes no 
Do you currently, or have you suffered from any symptom(s) of an injury (muscles, tendons, 
bones, ligaments or joints) within the past 12 months? (ONLY symptoms of an injury that was 
severe enough to interfere with exercise, or which required treatment, such as medication or 
intervention from a medical professional.) 
yes no 
If yes, please specify which symptom(s) and injury, and provide details: 
 
CRITERIA: Training needs to be LESS than three times per week, and LESS than 1 hour sessions 
In the past three months - 
How much time would you spend on average exercising or being active, per day? 
Please provide details: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  
 
How many days do you train, or are you involved in any form of activity, per week? 
Please provide details: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
 
_ _ _ _ _ _ _ _ hours/day  
 
 
_ _ _ _ _ _ _ _ days/wk 
 

























How many hours do you train on average, or are you involved in any form of activity, 
per week?  
Please provide details: _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
 
 
_ _ _ _ _ _ _ _ hours/wk 
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Appendix E: Consent form 
Participant Information Sheet 
 
Sweating away depression?  
The impact of intensive exercise on depression 
 
 You are invited to participate in a neuropsychological study conducted by the University of Cape 
Town (UCT) Psychology Department in collaboration with the Exercise Science & Sports Medicine 
(ESSM) division at the Sports Science Institute of South Africa. Please read this information sheet 
carefully and do not hesitate to ask the researcher for any additional information. 
 
 The overall purpose of this study is to investigate the influence of 3 different exercise protocols 
on depressive symptoms.  You will be required to attend three 60-minute exercise sessions per 
week, for six weeks (i.e. 18 sessions in total). 
 
 If you are placed in Groups 1 or 2, you will be required to complete two Peak Sustained Power 
Output (PSPO) test on a cycle ergometer to assess your maximum heart rate, which entails 
cycling progressively harder until fatigue, generally around 6-8 minutes.  You will have a small 
amount of blood taken once per week (i.e. on only one day of the week), both before and after 
the exercise. You will also be asked to complete three questionnaires once weekly. Two of these 
questionnaires measures depressive symptoms via external assessment. The other questionnaire 
is a self-report measure of personality and emotions. Finally, a medical doctor will examine you 
before you exercise to ensure that you are physically able to do so. 
 
 You are not eligible to participate in this study if you already have an exercise routine that 
exceeds a three-times weekly load of at least one hour, at an intensity of 70% of your Maximum 
Heart Rate. 
 
 You are not eligible to participate in this study if you are already being treated for depression 
either with therapy or antidepressant medication. 
 
 There are no anticipated risks involved in this research, but if you should experience any form of 
psychological or physical distress please be aware that you can inform the researcher/doctor 
immediately. Psychological support will be offered to you should you want it through either the 
University of Cape Town’s Student Wellness Service — Student Counseling Services (Tel: 021 650 
1017 / 1020), or alternatively, you can also consult your GP or a private psychologist. 
 
 It is up to you to decide whether or not you take part. If you decide to take part, you will be given 
this information sheet to keep and also asked to sign a separate consent form. If you decide to 
participate, you are still free to withdraw from the study at any time, without having to give a 
reason.  
 
 You will be reimbursed for the petrol/transport costs incurred in getting to the Sports Science 
Institute to participate in the study. If you are unable to get there yourself, an alternative 
transport arrangement can be organized.  
 
 The confidentiality of your data and your identity will be protected. All data collected will be 
suitably anonymous, securely stored, and made accessible only to the researcher. 
 
 This research will be carried out by researchers from UCT and ESSM, and is funded by the 
Institute for the Study of Affective Neuroscience (ISAN). 
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 This study has been reviewed by the UCT Psychology Department’s Ethics Committee and the 
UCT Health Sciences Faculty Human Ethics Research Committee (HREC).         
 
 If you have any questions regarding this study, or concerns regarding the manner in which the 
study was conducted, or would like to be informed of the results when the study is completed, 
please feel free to contact the principal researcher. 
 
Address/contact details for communications (Co-investigator): 
 
Dr Ross Balchin       Professor Marc Blockman 
Tel. 083 3731495                               Chair of Human Research Ethics Committee 
Email: rm.balchin@uct.ac.za  [For any questions concerning your 
rights and wellbeing as a participant]                                  























TITLE OF PROJECT: Sweating Away Depression?  
The impact of intensive exercise on depression 
Please cross out 
 as necessary 
Have you read the Participant Information Sheets?    YES/NO 
Have you had an opportunity to ask questions and  
discuss the study?        YES/NO 
Have you received satisfactory answers to all your questions?                 YES/NO 
Have you received enough information about the study?   YES/NO 
Who have you spoken to?  Dr/Mr/Mrs/Ms/Prof.  ……………………………................................. 
Do you understand that you are free to withdraw from the study: 
  -at any time 
  -without having to give a reason for withdrawing 
  -and without affecting your future treatment?                YES/NO 
 
Do you consent to the unattributed and confidential use of the data  
collected for scientific purposes?                   YES/NO 
 
Signed ………………………………   Date: …………………… 
 
(NAME IN BLOCK LETTERS) ……………………………………………… 
 
 
 
 
